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ABSTRACT 
 
CIRCADIAN REGULATION OF HEPATIC METABOLISM  
BY NUCLEAR RECEPTORS REV-ERB AND ROR 
Yuxiang Zhang 
Mitchell A. Lazar 
 
Circadian and metabolic physiology are intricately intertwined. Although the liver 
clock is entrained by the central clock, it also directly controls metabolic gene 
expression. Hormone responsive nuclear factors are hypothesized to be the 
major clock components that regulate metabolism, which include Rev-erbs and 
RORs. In this study, we explored the mechanism of regulation of liver circadian 
gene expression by Rev-erbs and RORs. We found that Rev-erbα modulates the 
clock and metabolism by different genomic mechanisms. Clock control requires 
Rev-erbα to bind directly to the genome at its cognate sites, where it competes 
with activating ROR TFs. By contrast, Rev-erbα regulates metabolic genes 
primarily by recruiting the HDAC3 corepressor to sites to which it is tethered by 
cell type-specific transcription factors.  Thus, direct competition between Rev-
erbα and ROR TFs provides a universal mechanism for self-sustained control of 
molecular clock across all tissues, whereas Rev-erbα utilizes lineage-determining 
factors to convey a tissue-specific epigenomic rhythm that regulates metabolism 
tailored to the specific need of that tissue. 
 
 vi 
In addition, we also investigate the circadian regulation of hepatic metabolism by 
nuclear receptors RORα and RORγ.  We discovered that hepatic depletion of 
RORs increased expressions of genes involved in lipogenesis as well as the 
hepatic triglyceride levels, specifically at ZT22 (5 AM) and during feeding, but not 
at ZT10 (5 PM) nor during fasting. GRO-seq analysis suggested that regulation 
of lipid metabolism by RORs was mediated by SREBP1-c. Indeed, ROR 
depletion significantly up-regulated nuclear SREBP1-c protein level specifically at 
ZT22. Overall, our study reveals a time-specific regulation of liver lipid 
metabolism by RORs, and suggests a potential role of chronotherapy targeting 
circadian factors in the treatment of metabolic disorders.  
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Background and Introduction 
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1.1 Nuclear Receptors Rev-erbs and RORs Link Circadian to Metabolism 
Circadian clock machinery, which exists almost in every living organisms and 
cells, is an adaption to the 24-hour oscillation of changes in internal and 
environmental factors, including light/dark cycles, time of food availability, 
temperature, activity/rest cycles, and so on. The master clock in mammals is 
located in the suprachiasmatic nucleus (SCN) of the hypothalamus. Many 
physiological processes are subject to circadian oscillations including lipid and 
carbohydrate metabolism, hormones (insulin, leptin, and cortisol) secretion, blood 
pressure, coagulation factors and feeding behaviors. Furthermore, disturbance of 
the circadian rhythms may have clinical implications in the development of 
dyslipidemia, obesity and cardiovascular events. Indeed, circadian rhythms in 
both insulin secretion and sensitivity are altered and circadian expressed genes 
are blunted in obese and type 2 diabetic patients (Boden et al., 1999). In addition, 
sleep restriction, shift working and night eating conditions have been associated 
with metabolic syndrome (Karlsson et al., 2001), further supporting the link 
between circadian oscillations and metabolism. 
 
1.1a Nuclear Receptors in Core Molecular Clock System 
On molecular level, the cellular circadian clock is maintained by a complex 
circuitry of transcriptional/post-translational regulatory loops. This loop starts from 
the positive limb Bmal1 and Clock, which activate transcription of Per and Cry, as 
well as the nuclear receptors Rev-erb and ROR. Post-translational regulators Per 
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and Cry, could repress Bmal1 and Clock activity in feedback. On the other hand, 
Rev-erb and ROR are transcriptional repressor and activator respectively that 
regulate Bmal1 and Clock transcription, serving as the other arm of the feedback 
loop circuit. It has been demonstrated that all isoforms of Rev-erbs and RORs 
could bind to the RORE motif in the promoter of Bmal1 and regulate Bmal1 
expression (Guillaumond et al., 2005). The competition between the two factors 
also leads to a transcriptional activity shift that could contribute to the robustness 
of Bmal1 transcriptional oscillation (Guillaumond et al., 2005). In addition, there is 
also an RORE near the transcriptional start site of Rev-erbα. Thus, Rev-erbα 
could also be regulated by Rev-erbs and RORs, which adds another layer of 
complexity of feedback circuit (Adelmant et al., 1996; Raspe et al., 2002). 
 
1.1b Expression and Functions of Rev-erbs and RORs 
Rev-erbs comprise two members, Rev-erbα and Rev-erbβ, which display 
rhythmic expression in many mammalian tissues such as the liver, white and 
brown adipose tissue, muscle, brain, and cell types such as endothelial cells 
(ECs), vascular smooth muscle cells and macrophages (Lazar et al., 1989; 
Dumas et al., 1994; Migita et al., 2004). Recent studies on the simultaneous 
disruption of Rev-erbα and β have revealed a redundant function in the molecular 
clock (Bugge et al., 2012; Cho et al., 2012). ROR has three isoforms, RORα, 
RORβ, and RORγ. RORα and RORγ are expressed in a number of tissues 
(Forman et al., 1994), whereas RORβ mRNA is restricted to the central nervous 
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system. RORα does not show clear circadian variation in the tissue it is 
expressed, while RORγ exhibits an oscillatory expression pattern in liver, brown 
adipose tissue, and kidney, but not in skeletal muscle and thymus (Guillaumond 
et al., 2005; Jetten and Joo, 2006). In general, nuclear receptors are composed 
of N-terminal activation domain (AF1), a DNA-binding domain (DBD), a central 
hinge region, and a C-terminal ligand-binding domain (LBD) with another ligand-
dependent activation function domain (AF2) observed in several nuclear 
receptors, including RORs. However, Rev-erbs lack the AF2 ligand-dependent 
transactivation domain, and thus constitutively repress transcription through 
recruitment of nuclear receptor co-repressor (NCoR) and HDAC3 (Yin and Lazar, 
2005), while RORs mainly activate transcription through recruitment of co-
activators SRC2 or Med1 (Atkins et al., 1999; Stashi et al., 2014). Both Rev-erb 
and ROR bind as a monomer to the RORE consisting of a 6bp core motif 
(A/G)GGTCA flanked by an A/T-rich 5’ sequence, and Rev-erb can also bind 
cooperatively as a homodimer to a RevDR2 element composed of a direct repeat 
of the core motif spaced by two nucleotides (Harding and Lazar, 1995).  
 
1.1c Post-Translational Modification of Rev-erbs and RORs 
Besides their oscillation in mRNA abundance, Rev-erbs could also be regulated 
on the post-translational level. Rev-erbα can be phosphorylated by GSK3b at its 
N-terminal, and phosphorylation protects Rev-erbα from ubiquitin-mediated 
degradation. Lithium is a potent inhibitor of GSK3b activity, and thus promotes 
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Rev-erbα degradation and activates Bmal1 transcription (Yin et al., 2006; Yin et 
al., 2010). More recently it was found that cyclin-dependent kinase 1(Cdk1) could 
also phosphorylate Rev-erbα and target it for ubiquitination and subsequent 
degradation by the F-box protein Fbxw7. Moreover, targeted hepatic disruption of 
Fbxw7 altered circadian expression of core clock genes and perturbed whole-
body lipid and glucose levels (Zhao et al., 2016). 
 
RORα could also be regulated by translational phosphorylation by protein kinase 
C (PKC), which inhibit RORα transcriptional activity (Duplus et al., 2008). On the 
other hand, ROR could also be regulated by small ubiquitin-like modifiers 
(SUMOs). SUMylation of RORα by both SUMO-1 and SUMO-2 on the 240th 
lysine residue at the hinge region of human proein, which enhance its 
transcriptional activity. PIAS family members increased SUMOylation of RORα, 
whereas SENP2 specifically removed SUMO from RORα (Hwang et al., 2009).  
 
1.2 Rev-erbs and RORs as Regulators of Central Clock and Brain Function 
Numerous studies have investigated the role of Rev-erbs and RORs in the 
regulation of central clock. Ueli Schibler and collaborators first evidenced a 
critical role of Rev-erbα in the clock machinery in vivo showing that Rev-erbα 
deficient mice display markedly altered circadian rhythms and a shorter period 
length (~0.5h) than wild-type mice (Preitner et al., 2002). In addition, 
heterozygous and homozygous staggerer mutant mice, which are deficient in 
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RORα, had shorter average locomotor activities but still sustain rhythmicity (Sato 
et al., 2004; Akashi and Takumi, 2005). Nonetheless, staggerer mutant also 
showed locomotor difficulties owing to cerebellar abnormalities, and had less 
overall activity of compared to the wild-type animals, which might interfere the 
interpretation of circadian phenotypes of staggerer mice (Akashi and Takumi, 
2005).  
 
In addition to its regulation of core clock, Rev-erbα could also regulate 
dopaminergic and hippocampus-dependent behaviors. Rev-erbα null mice were 
deficient in short-term, long-term, and contextual memories and also showed 
defective hippocampal function (Jager et al., 2014). Rev-erbα could also regulate 
midbrain dopamine production and mood-related behavior in mice, potential by 
repressing tyrosine hydroxylase gene transcription via competition with nuclear 
receptor-related 1 protein (NURR1), which is another nuclear receptor crucial for 
dopaminergic neuronal function (Chung et al., 2014). 
 
1.3 Role of Rev-erbs and RORs in Peripheral Tissues 
To function as a pacemaker and synchronizer for the peripheral clocks, the 
intrinsic timekeeping signal from the central clock has to be transmitted to the 
peripheral tissues via hormones, nervous system or behaviors, such as feeding. 
The peripheral clock components, particularly hormone and nutrients responsive 
nuclear receptors, Rev-erb and ROR, not only control clock genes to maintain 
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the robustness and integrity of the clock in each tissue, but also control a number 
of genes as clock output in different tissues. Their roles in tissue specific function 
have been studied extensively.  
 
1.3a Rev-erbs and RORs as Regulators of Liver Metabolism 
Studies have shown that Rev-erbs regulate whole body metabolism via the 
control of cholesterol and bile acid metabolism in liver.  In addition, Rev-erbα-
deficient mice displayed elevated serum and liver mRNA levels of apoC-III and 
increased serum VLDL triglycerides (Coste and Rodriguez, 2002; Raspe et al., 
2002) through RORE in the apoC-III gene promoter. In rats, Rev-erbα has also 
been shown to repress apoA-1 gene expression and plasma HDL-cholesterol 
levels, which also has an RORE in its promoter. Both apoA-1 and apoC-III are 
also regulated by RORα, illustrating the cross talk of these nuclear receptors on 
common target genes.   
 
The genome wide binding sites, or cistrome, of Rev-erbα has been defined in the 
liver using the chromatin-immunopreciptation followed by high-throughput 
sequencing (ChIP-seq). It binds to thousands of genomic locations and repress 
their transcription at ZT10, when its expression is maximal. Those binding sites 
are mostly gone at ZT22 due to the very low level of Rev-erbα protein. Pathway 
analysis of those binding sites revealed that fatty acid biosynthesis pathways are 
enriched near those binding sites, supported by the hepatic steatosis phenotype 
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in the Rev-erbα null mice (Bugge et al., 2012). Besides, similarly to the 
redundant function in the core clock, Rev-erbα and Rev-erbβ are also redundant 
in the maintenance of systematic and hepatic lipid homeostasis, demonstrated by 
the severer dysregulation of serum and hepatic triglycerides level in the mice 
deficient in both genes (Bugge et al., 2012; Cho et al., 2012). 
 
RORα and RORγ also regulate liver lipid, bile acid, and glucose pathway, but 
often through different pathways compared to Rev-erb regulation. It has been 
reported that RORγ could regulate rhythmic expression of several lipid metabolic 
genes, including the Insig2a, Elovl3 and Cyp8b1, by enhancing their expression 
at ZT20-4 (Takeda et al., 2014b). In addition, both RORγ and RORα deficient 
mice exhibit decreased gluconeogenesis and improved insulin sensitivity and 
glucose tolerance during daytime specifically (Takeda et al., 2014a; Kadiri et al., 
2015). However, reports on RORα regulation of hepatic triglyceride are not 
consistent. While some studies report RORα deficient staggerer mice had a 
decreased serum and liver triglycerides and lipogenic gene expression (Lau et al., 
2008; Kang et al., 2011), some others reported it had increased liver triglyceride 
accumulation and lipogenic gene expression (Wada et al., 2008). The differences 
in the experimental settings such as euthanizing time or feeding status at the 
time of euthanizing might be the factors that caused that inconsistency. 
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1.3b Rev-erbs and RORs as Regulators of Adipogenesis and 
Thermogenesis 
Rev-erbα mRNA is induced during adipocyte differentiation of 3T3-L1 cells, and 
promote adipocytes differentiation (Chawla and Lazar, 1993; Fontaine et al., 
2003; Wang and Lazar, 2008). However, mice lacking Rev-erbα has normal 
adipose tissue mass, if not more (Chomez et al., 2000; Delezie et al., 2012), 
possibly due to the compensation effects from other redundant factors such as 
Rev-erbβ. Interestingly, in BAT, Rev-erbα controls the circadian thermogenesis 
process. It is rhythmically expressed, peaking at ZT10 in mice, which is in the 
opposite phase as body temperature rhythm. Mice lakcing Rev-erbα were shown 
to have an attenuated nadir in temperature oscillation owing to derepression of 
uncoupling protein 1 (UCP1), which is a direct target of Rev-erbα in BAT 
(Gerhart-Hines et al., 2013). The role of Rev-erbβ has not been explored in the 
BAT.  
 
RORα deficient mice are resistant to age-induced WAT and BAT hypertrophy 
and exhibited a significantly lower total body fat index compared with WT 
littermates, while RORγ deficient mice developed adipose hypertrophy to a 
similar extend as WT littermates (Kang et al., 2011). It is further demonstrated 
that those RORα deficient mice had increased Ucp1 expression in both brown 
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adipose and subcutaneous white adipose tissue, (Lau et al., 2015), as well as 
decreased glyceroneogenesis (Kadiri et al., 2015). 
 
1.3c Rev-erbs and RORs as Regulators of Immune and Inflammation 
System 
The role of Rev-erbs in the immune system was mainly explored in macrophages. 
It was shown to mediate the circadian gating of the LPS-induced endotoxic 
response (Gibbs et al., 2012).  Notably, recent cistrome profiling of Rev-erbα and 
Rev-erbβ and global run-on sequencing that quantifies nascent 5’ ends in 
macrophage revealed that Rev-erbα repress macrophage genes by repressing 
eRNA transcription at a distance (Lam et al., 2013). Further, it could block pro-
inflammatory signals in macrophages by repressing the Toll-like receptor 4 
(TLR4) gene, which triggers the innate immune response to lipopolysaccharide 
(LPS) associated with Gram-negative bacteria (Fontaine et al., 2008).  It could 
also directly repress Ccl2 expression as well as CCL2-activated signals ERK and 
p38 in peritoneal macrophages (Sato et al., 2014).  
 
Interleukin 17 (IL-17) producing T helper 17 (Th17) cells are a major driver of 
autoimmune diseases and its cell lineage is dependent on RORγt. IL-17A 
expression is directly regulated by RORs through their interaction with ROREs in 
the Il17 promoter (Yang et al., 2008). In addition, RORγ-deficient mice lack lymph 
nodes and peyer’s patches indicating that it is essential for lymph node 
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development (Kurebayashi et al., 2000; Sun et al., 2000), and displayed a 
diminished susceptibility to auto-immune and inflammatory diseases such as 
allergen-induced lung inflammation and collagen-induced arthritis (Jaradat et al., 
2006; Tilley et al., 2007).  
 
1.3d Rev-erbs and RORs as Regulator of Muscle Metabolism 
Rev-erbα and Rev-erbβ are required for muscle cell differentiation and regulate 
genes involved in lipid absorption in C2C12 myocytes (Downes et al., 1995; 
Ramakrishnan et al., 2005). In addition, overexpression of Rev-erbα in C2C12 
myocytes was shown to increase mitochondrial content and activity by 
modulating the AMP-activated protein kinase (AMPK) pathway. Notably, loss of 
Rev-erbα function in mice skeletal muscle was shown to reduce mitochondrial 
content and function, leading to impaired exercise capacity (Woldt et al., 2013). It 
is shown that Rev-erbα could inhibit autophagy of mitochondria in this tissue and 
thus increase mitochondrial content and oxidative capacity of myocytes, by 
directly repress the autophagy and mitophagy genes.  
 
A study using the exogenous dominant negative RORα expression in skeletal 
muscle C2C12 cells demonstrated that RORs directly activated muscle genes 
involved in lipid homeostasis such as Srebp1, Fasn, and Scd1 (Lau et al., 2004). 
Recently, evidence was provided for a role of RORα in PI3K-Akt signaling. Akt1/2 
expression was up-regulated in skeletal muscle of RORαsg/sg mice and this 
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correlated with an increase in the level of insulin-induced Akt phosphorylation, 
Glut4 expression, and glucose uptake (Lau et al., 2011). RORγ has been 
reported to regulate the expression of genes associated with lipid and 
carbohydrate metabolism as well as the production of reactive oxygen species 
(Raichur et al., 2007).   
 
1.3f Rev-erbs and RORs in Other Tissues: Pancreas, Cancer 
Rev-erbs and RORs have also been shown to have a role in pancreas function. 
Rev-erbα mRNA is expressed in islets and oscillates with a circadian rhythm 
similar to that of liver. Intriguingly, Rev-erbα was found to regulate lipogenic 
genes in mouse islets (Vieira et al., 2012). Islet isolated at the time of peak Rev-
erbα expression have higher levels of glucose-stimulated insulin secretion, and 
Rev-erbα regulates gene expression as well as insulin processing, exocytosis, 
and proliferation in primary β cell and β cell lines (Vieira et al., 2012). Rev-erbβ is 
also expressed in both α cells and β cells although its role in islets remains to be 
investigated (Chuang et al., 2008). All ROR members are expressed in rat 
pancreas islets, with the highest expression in α-cells (Muhlbauer et al., 2013). 
RORα and RORγ, but not RORβ have circadian mRNA expression in rat 
pancreas, but the their functional role in islet have not been investigated. Rev-
erbs and RORs could also be detected in other tissues including cancer, and has 
been involved cellular stress response and cytotoxicity processes in cancer (Zhu 
et al., 2006; De Mei et al., 2015). 
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1.4 Endogenous and Synthetic Ligands for Rev-erbs and RORs 
The original orphan nuclear receptors Rev-erbs and RORs have been adopted 
recently, with heme identified as endogenous ligands for Rev-erbs, and 
cholesterol and cholesterol derivatives as the putative ligands for RORs. 
Melatonin was initially suggested as a ligand for RORs but later turned out not 
directly activate RORs (Slominski et al., 2016). Besides, several synthetic 
agonists have been identified for Rev-erbs and RORs. Rev-erb agonists have 
been shown to disrupt rhythmic wheel-running behavior and circadian 
hypothalamic gene expression in mice, and can also alter whole-body 
metabolism (Solt et al., 2012), while ROR inverse agonists inhibited the 
differentiation of splenocytes that were cultured under conditions to produce 
TH17 cells and this inhibition was associated with inhibited expression of several 
cytokines, including IL17A, IL17F, IL21 and IL22 (Solt et al., 2011). However, it is 
still not clear whether the phenotypes caused by the compounds treatment are 
through targeting Rev-erbs and RORs, or off-target effects.  Future studies for 
those compounds using Rev-erbs or RORs null mice as negative control are 
needed to demonstrate the functional specificity of those compounds.   
 
1.5 Hypothesis and Objectives 
In mammals, tissue specific metabolic processes in peripheral organs are 
synchronized with robust circadian rhythms to coordinated with the daily cycles of 
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light and nutrient availability. Circadian disruption has been associated with 
various diseases including metabolic dysfunction and cardiovascular disorders. 
Nuclear receptors Rev-erbs and RORs are hypothesized to be the link 
connecting the circadian clock with metabolism. In this dissertation, we explore 
the role of nuclear receptors Rev-erbs and RORs in the circadian regulation of 
hepatic metabolism. First we hypothesize that Rev-erbα and RORα compete with 
each other to control the clock genes and circadian genes transcription. To 
address this hypothesis, in Chapter 3, we profile Rev-erbα and RORα in mouse 
liver genome at different times of the day and revealed that Rev-erb compete 
with ROR at the sites where it directly binds to DNA, but they could also be 
tethered to the chromatin by lineage determining factors. It is found that Rev-erb 
controls core clock gene expression through the direct binding sites, and regulate 
metabolic processes through the tethering sites. In Chapter 4, we examine how 
RORs regulate the liver circadian metabolism. Chapter 5 summarizes the work 
and discussed the future directions.  
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CHAPTER 2 
Materials and Methods 
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Animal studies  
Male wild type inbred C57BL/6 and 129S1/SvlmJ mice were purchased from 
Jackson Labs. The Rev-erbα knockout mice were obtained from B. Vennström 
and backcrossed seven or more generations with C57BL/6 mice (9). The 
HDAC3fl/fl mice were described previously (9). Mice carrying floxed alleles at 
Rev-erbα or Rev-erbβ loci were obtained from MCI/ICS (Mouse Clinical 
Institute—Institut Clinique de la Souris, Illkirch-Graffenstaden; http://www.ics-
mci.fr/), as reported previously (12, 23). RORα floxed mice were obtained from 
MCI/ICS, and RORγ floxed mice were obtained from Jackson Laboratory. The 
HNF6fl/fl mice were on a C57BL/6 background and have been described 
previously (Zhang et al., 2009). Mice were housed on a temperature-controlled 
specific-pathogen free facility with 12:12-hour light–dark cycle (lights on at 07:00, 
lights off at 19:00).  
 
Experiments were carried out on 12–16-week-old male mice. The Penn Vector 
Core generated the AAV vectors (AAV8-Tbg-GFP and AAV8-Tbg-Cre). We 
injected each AAV vector intravenously at 1.5 × 1011 genome copies per mouse 
and characterized the mice at 3–4 weeks after AAV injection for chow diet fed 
mice and at 5 weeks after injection for HFD fed mice. HFD containing 60 kcal % 
fat was purchased from Research Diets Inc. (D12492i). We harvested tissues at 
specified time without restricting the mice to food or water.  
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We performed glucose tolerance tests at 3 weeks after AAV injection, and after 
fasting for 16 hours, beginning at 5 p.m. We performed insulin tolerance tests at 
4 weeks after AAV injection, and after fasting for 6 hours, beginning at 9 a.m. For 
the glucose tolerance test, we injected glucose intraperitoneally at 1.5 g per kg 
body weight. For the insulin tolerance test, we intraperitoneally injected insulin 
(Novolin R) into the mice at 0.6 U per kg body weight. We measured blood 
glucose concentration using a glucometer (OneTouch) by sampling from the tail. 
All animal studies were performed with an approved protocol from the University 
of Pennsylvania Perelman School of Medicine Institutional Animal Care and Use 
Committee. 
 
ChIP 
Mouse liver, brain (ventral tegmental area), and epididymal white adipose tissue 
(eWAT) were harvested, minced and cross-linked in 1% formaldehyde for 20min, 
followed by quenching with 1/20 volume of 2.5M glycine solution for 5 min, and 
two washes with 1×PBS. Nuclear extracts were prepared by Dounce 
homogenization in ChIP buffer (50mM Tris-HCl pH 7.5, 140mM NaCl, 1mM 
EDTA, 1% Triton X-100, 0.1% NaDOC). Chromatin fragmentation was performed 
by sonication in lysis buffer (50mM Tris-HCL ph 8.0, 0.1%SDS, 10mM EDTA), 
using the Bioruptor (Diagenode). Proteins were immune-precipitated in ChIP 
buffer, and crosslinking was reversed overnight at 65°C in SDS buffer (50mM 
Tris-HCL, 10mM EDTA, 1% SDS, pH 8), and DNA isolated using 
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phenol/chloroform/isoamyl alcohol. Precipitated DNA was analyzed by 
quantitative PCR or high-throughput sequencing.  
 
ChIP-Re-ChIP 
ChIP-Re-ChIP was performed in essentially the same way as ChIP, except that 
the first elution was carried out in a reducing elution buffer (1% SDS, 10 mM 
DTT), shaking at 800 rpm for 15 min at 65°C. The Rev-erbα ChIP eluate was 
then diluted in ChIP dilution buffer with 0.1 mg/ml BSA and 2ug/ml lamda DNA-
HindIII digest, divided into two, and subjected to HNF6, Rev-erbα, or IgG ChIP. 
 
Quantitative PCR 
Quantitative PCR was performed with Power SYBR Green PCR Mastermix and 
the PRISM 7500 instrument (Applied Biosystems), and analysis was performed 
by the standard curve method. Primers for gene expression and ChIP-PCR used 
were listed in Table 2.1 and Table 2.2. 
 
ChIP-seq 
ChIP experiments were performed independently on liver samples from individual 
mice harvested at indicated times. DNA was amplified according to ChIP 
Sequencing Sample Preparation Guide provided by Illumina, using adaptor oligo 
and primers from Illumina, enzymes from New England Biolabs (NEB) and PCR 
Purification Kit and MinElute Kit from QIAGEN. Deep sequencing was performed 
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by the Functional Genomics Core of the Penn Diabetes Endocrinology Research 
Center using the Illumina HiSeq2000, and sequences were obtained using the 
Solexa Analysis Pipeline. 
 
ChIP-seq data processing 
Sequencing reads of biological replicates were pooled and aligned to the mm9 
genome using bowtie (Langmead et al., 2009), followed by peak calling. Genome 
browser tracks of ChIP-seq data were generated using Homer v4.7 (Heinz et al., 
2010) and visualized in IGV (Robinson et al., 2011). For the comparison of Rev-
erbα cistromes in multiple tissues, and HNF6 and RORs cistromes in liver, peaks 
higher than 1 read per million (rpm) were used, and motifs mining was performed 
using Homer in 200bp regions surrounding the peak centers. RORa and RORg 
liver combined cistromes were determined by pooling their peaks found at ZT10 
and ZT22. To eliminate potential bias from different reading depths, 20 million 
reads were selected by random sampling from Rev-erbα ChIP-seq data in WT 
and DBDm and subjected to downstream analysis. Rev-erbα ChIP-seq in aKO 
mice was also analyzed using the same number of reads to eliminate false 
positive binding. Similarly, 10 million randomly sampled reads from HDAC3 
ChIP-seq in WT, Rev-erb DBDm, and Rev-erbαKO/βKD mouse livers were used 
for the peak height quantification. Among Rev-erbα peaks that are great than 
1rpm and at least 3 times stronger than their counterpart in Rev-erbα KO, DBD-
dependent Rev-erbα sites were selected using the cutoff: tag count fold change 
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WT/DBDm >3 or tag count difference WT-DBDm > 3 rpm; DBD-independent Rev-
erbα sites were selected using cutoff: tag count fold change WT/DBDm < 1.5 and 
DBDm/WT < 1.5. DBD-dependent Rev-erbα sites with reduced HDAC3 binding in 
DBDm liver (HDAC3 WT/DBDm > 1.5 and WT>1rpm) were defined as DBD-
dependent Rev-erbα/HDAC3 sites. DBD-independent Rev-erbα sites with intact 
HDAC3 binding in DBDm liver (HDAC3 WT/DBDm < 1.5 and WT>1rpm) were 
defined as DBD-independent Rev-erbα/HDAC3 sites. All ChIP-seq peaks were 
annotated by Homer using the nearest mapping within 50kb of gene TSSs. The 
functional Rev-erbα binding sites were defined as binding sites with up-regulated 
eRNA (tag count KO/WT fold change > 2.5) as determined by GRO-seq in 
wildtype and Rev-erbα KO liver at ZT10 (Fang et al., 2014). ChIP-seq data are 
available in GEO (GSE67973, GSE83791). 
 
SNP mediated strain-specific binding 
Rev-erbα ChIP-seq reads from 129 mice were aligned to the mm9 reference 
genome using GSNAP (Wu and Nacu, 2010), allowing mismatches at ~5.4 
million SNPs specific to 129 genome (Keane et al., 2011). To minimize potential 
bias introduced by different IP efficiency in B6 and 129 mice, Rev-erbα peaks 
identified in two strains were pooled and their peak heights were quantile 
normalized prior to the analysis of strain-specific binding. Rev-erbα peaks where 
Fimo (Keane et al., 2011) predicted HNF6 motif score was altered by the SNP, 
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from one strain to the other, were selected, and their log2 fold change of peak 
heights in two strains were calculated.   
 
ChIP-exo 
The ChIP-exo portion of the protocol was performed as described (Rhee and 
Pugh, 2011) with modifications making the assay compatible with the Illumina 
sequencing platform. Briefly, it was performed in essentially the same way as 
ChIP-seq, except that after the end repair, adapter ligation and nick repair, the 
DNA was digested by the lambda (M0262, NEB) and RecJf exonucleases 
(M0264, NEB), while it is still on the agarose beads. Then, the DNA samples 
were eluted from the beads and are analyzed by high-throughput sequencing. 
 
ChIP-exo data processing 
Rev-erbα ChIP-exo reads from two biological replicates were pooled and aligned 
to the mouse genome (mm9) using bowtie (Langmead et al., 2009) with 
parameters ‘-n 1 and -m 1’. Genome browser track of aligned reads were 
generated using Homer with the parameter -fragLength 10 and visualized in IGV. 
ChIP-exo peak call on the forward and reverse strands was performed using 
MACE-1.0 with default parameter (Wang et al., 2014). The most prevalent ChIP-
exo peaks were selected from within published Rev-erbα ChIP-seq peaks (Fang 
et al., 2014). Two approximate exo-peaks on different DNA strands (a peak pair) 
with distance from -50bp to +150bp (center of negative strand peak – center of 
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positive strand peak), was found using the windowBed feature of bedtools-2.21 
(Quinlan and Hall, 2010). Peak pairs with a distance less than +/-2 bp from the 
most prevalent distance of all peak pairs were selected. Motif search was 
performed in 30bp regions surrounding the peak pair centers using Homer. HNF6 
ChIP-exo (Wang et al., 2014) data were reprocessed using the same protocol. 
ChIP-exo data are available in GEO (GSE67973). 
 
Global Run-on Sequencing 
Nuclei Extraction. Mouse liver was harvested at indicated time and washed with 
cold swelling buffer (10 mM Tris pH 7.5, 2 mM MgCl2, 3 mM CaCl2, 2 U/ml 
Superase-In). Nuclear extract was prepared by dounce homogenization in cold 
swelling buffer and filtered using the cell strainer (100 µm, BD Biosciences). 
Lysate was centrifuged at 400 g for 10 min, then resuspended in lysis buffer 
(swelling buffer with 10% glycerol and 1% Igepal) and incubated on ice for 5 min. 
Nuclei were washed twice with lysis buffer, and resuspended at the concentration 
of 10x107 nuclei/ml in freezing buffer (50 mM Tris pH 8.3, 40% glycerol, 5 mM 
MgCl2, 0.1 mM EDTA). For each library, run-on was performed on 4x107 nuclei. 
 
Nuclear Run-On. Nuclei were mixed with an equal volume of run-on buffer (10 
mM Tris pH 8.0, 5 mM MgCl2, 1 mM DTT, 300 mM KCl, 200 U/ml Superase-In, 1% 
Sarkosyl, 500 µM ATP, GTP and Br-UTP, 2 µM CTP) and incubated for 5 min at 
30°C. Nuclear RNA was extracted with Trizol (Invitrogen) and treated with DNase 
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(Ambion). RNA was hydrolyzed using fragmentation reagents (Ambion) for 13 
min at 70°C and purified through a Micro Bio-Spin Column P-30 (Bio-Rad). RNA 
was treated with T4 polynucleotide kinase (New England Biolabs) for 1h at 37°C, 
then with an additional T4 polynucleotide kinase for 1h more, and inactivated for 
5 min at 75°C. 
 
NRO-RNA Immunoprecipitation. Anti-BrdU agarose beads (Santa Cruz) were 
rotated for 1h in blocking buffer (0.25x SSPE, 38 mM NaCl, 1 mM EDTA, 0.05% 
Tween- 20, 0.1% PVP, and 0.1% BSA). Then NRO-RNA was rotated with beads 
for 1h, followed by washes twice in binding buffer (0.25x SSPE, 38 mM NaCl, 1 
mM EDTA, 0.05% Tween-20), twice in low salt buffer (0.2x SSPE, 1 mM EDTA, 
0.05% Tween-20), once in high salt buffer (0.2x SSPE, 1 mM EDTA, 0.05% 
Tween-20, 138 mM NaCl), and twice in TET buffer (TE pH 7.4, 0.05% Tween-20). 
BrdU-labeled RNA was eluted from the beads four times for 10 min with 100 µl 
elution buffer preheated to 42°C. RNA was precipitated by adding 300 mM NaCl, 
1 µl of glycogen and 2.5 volumes of ethanol and incubated overnight at 20°C. 
RNA was resuspended in water (with 1 U/µl Superase-In and 0.05% Tween-20), 
denatured for 3 min at 65°C, and treated with poly(A)-polymerase (New England 
Biolabs) for 30 min at 37°C. 
 
cDNA Library Preparation. Synthesis of cDNA from RNA was performed as 
described previously (Wang et al., 2011) using oNTI223 primer (5’ -/5Phos/GA 
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TCG TCG GAC TGT AGA ACT CT/idSp/CAA GCA GAA GAC GGC ATA CGA 
TTT TTT TTT TTT TTT TTT TTV N-3’) where the ‘‘5Phos’’ indicates 50 
phosphorylation, ‘‘idSp’’ indicates the abasic dSpacer furan, and ‘‘VN’’ indicates 
degenerate nucleotides. The reaction was treated with exonuclease I (Fermentas) 
for 15 min at 37°C, followed by 100 mM NaOH for 20 min at 98°C, and 
neutralized with 100 mM HCl. cDNA was denatured at 70°C for 3 min, and run on 
10% TBE-urea gel, then products from 105-400 nucleotides size were excised 
and eluted from shredded gel pieces for 4h in TE + 0.1% Tween and precipitated 
by adding 1 ml of glycogen, 300 mM NaCl and 2 volumes of ethanol and 
incubated overnight at −20°C. cDNA was resuspended into circularization 
reaction and circularized with CircLigase (Epicenter) for 1 hr at 60°C, denatured 
for 10 min at 80°C, and relinearized by adding relinearization mix (25 mM KCl, 
500 mM DTT) and APE I (15U; New England Biolabs). Linearized DNA was 
amplified by PCR using Phusion Hot Start II Kit, according to manufacturer’s 
instructions. The oligonucleotide primers oNTI200 (5’ -CAA GCA GAA GAC GGC 
ATA-3’ ) and oNTI201 (5’ -AAT GAT ACG GCG ACC ACC GAC AGG TTC AGA 
GTT CTA CAG TCC GAC G-3’ ) were used for amplification. The PCR product 
was run on a 10% TBE gel and products from 150-305 nucleotides size were 
eluted from shredded gel pieces for 4h in TE + 0.1% Tween + 150 mM NaCl and 
purified using ChIP DNA Clean and Concentrator Kit (Genesee Scientific). 
Libraries were sequenced on an Illumina HiSeq2000 with sequencing primer 5’ -
CGA CAG GTT CAG AGT TCT ACA GTC CGA CGA TC-3’. 
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GRO-Seq Data Processing. GRO-seq sequencing reads were mapped to the 
mouse genome (mm9) using Bowtie v0.12.8 (Langmead et al., 2009) with 
parameters ‘-n 1 -l 20 -m 1 –f’. Uniquely mapped reads were extended to 150bp 
in the 5’ to 3’ direction and used for downstream analysis. Bedgraph files were 
generated using HOMER v4.3 (Heinz et al., 2010) and visualized using 
Integrative Genomics Viewer (Robinson et al., 2011). 
 
Gene Quantification. GRO-seq signal in gene bodies progressively decreases 
from 5’ to 3’ in general due to the nature of mRNA transcription (Hah et al., 2013). 
In addition, GRO-seq signal can accumulate at the TSS of low- or nontranscribed 
genes due to Pol2 pausing (Hah et al., 2013). To minimize the influence of these 
issues, nascent transcription of genes was measured using GRO-seq reads 
mapped to the sense strand of the gene in a 10kb window (+2kb to +12kb 
relative to the TSS) within the Refseq annotated gene body. Smaller genes 
between 2kb and 12kb in length were quantified using smaller window size, from 
+2kb to the transcription end site (TES). For genes shorter than 2kb, the entire 
gene body was used for the quantification. The mapped reads within each gene 
quantification window were counted using HOMER and expressed as read per kb 
per ten million reads (RPKTM). Genes with transcription levels greater than 5 
RPKTM were considered as being actively transcribed. 
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De Novo Identification of eRNAs. GRO-seq reads mapped to the plus and 
minus DNA strand were separated and subjected to downstream processes. 
Unlike gene transcripts, eRNA transcripts are normally short and form sharp 
peaks that were identified by HOMER (0.1% FDR). Candidate peaks were then 
filtered against local background in ± 10kb window surrounding the peak using a 
3-fold cutoff. Peaks passing the filtering step from each DNA strand were 
subsequently pooled for further analysis. Bidirectional eRNA loci were identified 
by searching for paired eRNA peaks from opposite DNA strands, such that the 
plus strand peak center had a greater genomic coordinate than the minus strand 
peak center, and the distance between the 5’ ends of the peak pair was < 1kb. 
Unpaired peaks were further divided into inter- and intragenic peaks. Intergenic 
peaks and the subset of intragenic peaks located on the antisense strand of 
Refseq genes were defined as uni-directional eRNAs. Based on a comparison of 
ChIP-seq signal density for numerous liver TFs at eRNA loci, the center of each 
bidirectional eRNA locus was set to the middle point of the 50 ends of the paired 
peaks, whereas the center of each uni-directional eRNA locus was set to 200bp 
upstream from the 5’ end of the eRNA peak. Bi- and unidirectional eRNA loci 
identified in each GRO-seq sample were merged for subsequent analysis. Only 
those loci identified in 2 or more samples were selected. Finally sites located 
within 300bp of Refseq TSSs were excluded.  
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Quantification of eRNAs. eRNA level was quantified by calculating GRO-seq 
reads mapped within ± 500bp of eRNA locus center using HOMER, and 
normalized to RPKTM. For unidirectional intergenic eRNAs, tag count was 
performed on the DNA strand where the eRNA peak was identified. For 
intragenic eRNAs, tag count was performed on the antisense strand of the 
coding gene.  
 
Western blot and gene expression analysis 
For the western blot of the total lysates, we lysed tissues or cells in radio-
immuno-precipitation assay (RIPA) buffer supplemented with phosphatase and 
protease inhibitors, resolved the samples by Tris-glycine SDS-PAGE, transferred 
the samples to a nitrocellulose membrane and blotted them with the indicated 
antibodies. For qRT-PCR, we extracted total RNA using TRIzol (Invitrogen) and a 
High Pure RNA tissue kit (Roche). We performed qRT-PCR with a High Capacity 
RT kit, a SYBR Green PCR Master Mix and the PRISM 7500 instrument (ABI) 
using the absolute quantification method with standard curves. 36B4 (Arbp) was 
used as housekeeping control.  
 
Microarray Analysis 
Liver samples were taken from 12 week old male RORafl/flgfl/fl mice 2 week after 
injection of AAV-Cre or AAV-GFP virus (4 mice per group). Total RNA was 
extracted from each liver sample using the RNeasy Mini Kit (Qiagen). Each RNA 
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sample was processed with the Ambion WT Expression Kit and the GeneChip 
WT Terminal Labeling and Controls Kit (Affymetrix), and hybridized to the Mouse 
Gene 2.0 ST Array (Affymetrix). The array was then read by GCS3000 laser 
scanner (Affymetrix), and microarray data analysis was carried out using Partek® 
Genomics Suite software (Copyright, Partek Inc.). Subsequent data analysis was 
performed using BioConductor. ROR target genes were selected using threshold 
p<0.01, expression fold change < -1.3 and compared with Rev-erbα target genes 
previously identified using equivalent cutoffs (Lam et al., 2013). For comparison 
between Rev-erbα target genes and DBDm target genes, p<0.05 and expression 
fold change > 1.3 were used, and only those containing at least one Rev-
erbα binding site within 50kb of their TSSs were compared. The procedures were 
performed by the Penn Digestives Disease Center Morphology Core. Microarray 
data are available in GEO (GSE67973). 
 
Mass spectrometric identification of Rev-erbα 
Rev-erbα antibody (Cell signaling Technology #2124) was covalently linked to 
AminoLink™ Coupling Resin (Thermo). Tissue was lysed in RIPA with protease 
inhibitors and sonicated. Cleared lysates were incubated with 100 µl of resin 
overnight at 4°C, washed in RIPA, eluted in 10% NH4OH, and dried. Samples 
were prepared for MS as previously described (37). After reduction/alkylation, 
samples were digested with Lys-C (Wako) followed by trypsin (Promega) at 37°C. 
Samples were resuspended in 1% acetic acid, and desalted with C18 stage tips 
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as previously described (38). EASY-nanoLC (Thermo) was configured with a 75 
µm ID x 17 cm Reprosil-Pur C18-AQ (3 µm; Dr. Maisch GmbH, Germany) nano-
column and coupled with an Orbitrap Fusion mass spectrometer (Thermo). Full 
scan MS spectrum (m/z 360−1600) was performed in the Orbitrap with a 
resolution of 120,000 (at 200 m/z). Fragmentation was performed with higher-
energy collisional dissociation (HCD) and a maximum injection time of 120 msec. 
MS/MS data were collected in centroid mode in the ion trap mass analyzer. Peak 
area was extracted from raw files by using Proteome Discoverer v1.4 and 
peptides were identified using MASCOT.  
 
Hepatic triglyceride assay 
Liver samples were homogenized in the TissueLyser (Qiagen) with steel beads in 
tissue lysis buffer (140mM NaCl, 50mM Tris and 1% Triton-X, pH8.0). 
Triglyceride concentration in the lysates was then quantified using LiquiColor 
Triglyceride Procedure No. 2100 (Stanbio). 
 
Oil Red O staining 
5µM frozen sections were prepared from snap-frozen liver tissues. The sections 
were stained in 0.5% Oil Red O in propylene glycerol overnight for lipid and then 
in hematoxylin for nucleus for 5 seconds. The procedures were performed by the 
Penn Digestives Disease Center Morphology Core. 
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Antibodies 
Rev-erbα antibody was purchased from Cell Signaling Technology (#2124). 
HDAC3 antibodies were purchased from Abcam (ab7030). HNF6 antibody was 
purchased from Santa Cruz Biotechnology (sc13050). RORα antibody from 
Santa Cruz Biotechnology (sc6062). RORγ antibody was purchased from Santa 
Cruz Biotechnology (sc28559). Rabbit IgG was from Santa Cruz Biotechnology 
(sc2027).  
 
Constructs and gene transductions 
The adeno-associated viruses encoding Cre recombinase (AAV-Cre), GFP 
(AAV-GFP) and flag-tagged Rev-erbα were obtained from the Vector Core of the 
Penn Diabetes Research Center. The Cre, GFP or flag-taggered Rev-erbα gene 
was inserted into the AAV2/8 vector containing the liver specific Tbg promoter. 
Each 12 week old male floxed mouse received 1.5 ×1011 particles of virus 
through tail-vein injection. The adenoviruses encoding shRNA targeting the b-
galactosidase (TGCACCTGGTAAATCTTAT) or the Rev-erbβ gene 
(GCACTAAGGACCTTA ATAATG) were constructed using the BLOCK-
iTadenoviral RNAi expression system from Invitrogen (#K4941-00) and 
subsequently amplified and purified by the Vector Core. Each mouse received 
5.7×1011 particles of virus through tail vein injection.  
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Table 2.1 List of Primers for Gene Expression 
RT-qPCR Primers 
Site Name Forward Primer Reverse Primer 
Arbp TCCAGGCTTTGGGCATCA CTTTATCAGCTGCACATCACTCAGA 
HNF6 AGACCTTCCGGAGGATGTG TGGACGTCTGTGAAGACCAG 
Bmal1 TAGGATGTGACCGAGGGAAG TCAAACAAGCTCTGGCCAAT 
Npas2 GACGCAACCAGCTTTAACCAAT CCAGACACGTTACCATCAGGAG 
Cry1 AGCGCAGGTGTCGGTTATGAGC ATAGACGCAGCGGATGGTGTCG 
Per1 GCCGCTTACAGCAGTCTAATGA GGCAGTTTCCTATTGGTTGGTC 
E4bp4 GCTCTTTTGTGGACGAGCAT ACCGAGGACACCTCTGACAC 
RORα TGTTTGATTGATCGGACCAG CTTGGACATCCCGACCAAACT 
RORγ ACTACGGGGTTATCACCTGTGAG GTGCAGGAGTAGGCCACATTAC 
Lpl TTTTCTGGGACTGAGGATGG GCCAGCTGAAGTAGGAGTCG 
Scd1 GCCCCTACGACAAGAACATT CATGCAGTCGATGAAGAACG 
Acacb ATTGCCAAGAGAATCCCTGT TCCACTCCAGGGTAAGGTTG 
Cd36 CCACAGTTGGTGTGTTTTATCC TCAATTATGGCAACTTTGCTT 
Fasn AAGTTCGACGCCTCCTTTTT TCTCGGGATCTCTGCTAAGG 
Elovl5 GAACATTTCGATGCGTCACT GGATGTAATTGTCCAGGAGGA 
Acss3 AATGTCGCAAAGTAACAGGCG GTGGGTCTTGTACTCACCACC 
Plin2 
AAGAGGCCAAACAA- 
AAGAGCCAGGAGACCA 
ACCCTGAATTTTCTG- 
GTTGGCACTGTGCAT 
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Table 2.2 List of Primers of ChIP-PCR 
ChIP-qPCR Primers 
Site Name Forward Primer Reverse Primer 
Arbp GAGGTGGCTTTGAACCAGAG TCTTTGTCTCTGTCTCGGAAAA 
Insulin GGACCCACAAGTGGAACAAC GTGCAGCACTGATCCACAAT 
Bmal1 AGCGGATTGGTCGGAAAGT ACCTCCGTCCCTGACCTACT 
Npas2 CTGTCTTGGCTAGGGGTTTG GAGACAGGCGAGAATCCAAG 
DBD dependent 
site 1 GAGATTGGGTCACCACAGGT GTGACCCAGCCACCTATGAC 
DBD dependent 
site 2 ATTCCCTACTGCCCCAATTC TTGTCCCACTCAAACAGCAG 
DBD dependent 
site 3 TGTCTCCTCCCACAGGAAAA CACTGCCCTCTCTCCTTTTG 
DBD independent 
site 1 TAGGGCTCTGCAGATTAGCC GCCCATGTGAAAATGGATGT 
DBD independent 
site 2 CCCTGGAAGTATAAGCGAGACA GGGTTCAGGGTTCCATTCTT 
DBD independent 
site 3 CATGCAATCGCTGACAGAAT AAGGGGTATGGAGTCGGAGT 
Better HNF6 motif 
in C57BL/6J site 1 TCCCAGTGTGAAGGTTTTGTT GCTTGATGATGTGGCTGAGA 
Better HNF6 motif 
in C57BL/6J site 2 TTTCCGTGTTGTGTGTTTTCA AAGCGCTAATTGAGCAAATCA 
Better HNF6 motif 
in C57BL/6J site 3 GACGATTTGCCATGTTTCCT CATGTTCTCTCTGCCGAGGT 
Better HNF6 motif 
in 129S1/SvlmJ 
site 1 
TGATAAATCCCTGGCCTTTG GCAGAGCTGCTTGGAAAGTC 
Better HNF6 motif 
in 129S1/SvlmJ 
site 2 
TTCCGGGAGAAACTGTAAGC GGGTATCGATTTGACCCGTA 
Better HNF6 motif 
in 129S1/SvlmJ 
site 3 
GGATGCAGAAGCAGCAATAA CTGCTGACACTGAACCAGGA 
Same HNF6 motif 
in both strains site 
1 
TGAGACCAAGGCTCAAAAGAA ACAAAGTGCACAGCTTGGAA 
Same HNF6 motif 
in both strains site 
2 
CAGTGGCAATGCTTCTGTGT TTGCAGCTGGACTCTGAGC 
Same HNF6 motif 
in both strains site 
3 
TGAACCCTGTAAAGCAGACCA CCCGTACCGTTCCTGTAGTC 
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Discrete Functions of Nuclear Receptor Rev-erbα  Couple 
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3.1 Abstract 
Circadian and metabolic physiology are intricately intertwined, as illustrated by 
Rev-erbα, a transcription factor (TF) that functions both as a core repressive 
component of the cell autonomous clock and as a regulator of metabolic genes. 
Here we show that Rev-erbα modulates the clock and metabolism by different 
genomic mechanisms. Clock control requires Rev-erbα to bind directly to the 
genome at its cognate sites, where it competes with activating ROR TFs. By 
contrast, Rev-erbα regulates metabolic genes primarily by recruiting the HDAC3 
corepressor to sites to which it is tethered by cell type-specific transcription 
factors.  Thus, direct competition between Rev-erbα and ROR TFs provides a 
universal mechanism for self-sustained control of molecular clock across all 
tissues, whereas Rev-erbα utilizes lineage-determining factors to convey a 
tissue-specific epigenomic rhythm that regulates metabolism tailored to the 
specific need of that tissue. 
 
3.2 Introduction 
Circadian rhythmicity is a common feature of nearly all physiological processes 
(Feng and Lazar, 2012). Each cell of the body contains a molecular clock 
comprised of transcription factors that act on one another in interlocking 
feedback loops that generate near-24 hour oscillations (Bass and Takahashi, 
2010). A core component of the molecular clock, the nuclear receptor Rev-erbα, 
is expressed with a circadian rhythm (Bugge et al., 2012) and represses BMAL1, 
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a positive regulator of clock output genes (Preitner et al., 2002). Rev-erbα 
represses many genes, often to regulate metabolism in a circadian and tissue-
dependent manner (Feng et al., 2011; Gerhart-Hines et al., 2013; Woldt et al., 
2013). Thus, Rev-erbα is central to complex interactions between the core clock 
and metabolism.  
 
Rev-erbα recruits the NCoR-HDAC3 complex to actively repress Bmal1 
transcription (Yin and Lazar, 2005). It could also compete with another nuclear 
receptor ROR for the DNA binding site, which contains RevDR2/RORE motifs 
bound by both receptors (Forman et al., 1994; Giguere et al., 1994; Harding and 
Lazar, 1995). The a and g isoforms of ROR are most abundant in liver (Solt and 
Burris, 2012), and are expressed in a circadian manner with a peak at ZT18, 
antiphase to Rev-erbα (Takeda et al., 2012), although the circadian variation of 
RORα is modest and of unclear biological significance (Takeda et al., 2012). 
Liver specific deletion of RORα and γ has been shown to markedly dampen the 
circadian oscillation of core clock genes in liver (Takeda et al., 2012). In this 
study, I aim to investigate the mechanism of circadian regulation of hepatic 
metabolism by Rev-erbα by analyzing its own cistrome and compare to the 
cistromes of RORs. 
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3.3 Results 
3.3a Rev-erbα Represses Clock Genes by Competing with RORα at Its 
Cognate Sites  
Since Rev-erbα is a core clock component but also has tissue-specific functions, 
we were interested in comparing its cistromes in different mouse tissues 
including liver, brain, and epididymal adipose tissue. The majority of Rev-erbα 
binding sites were tissue-specific (Figure 3.1A), and gene ontology analyses 
were consistent with specialized functions of Rev-erbα (Figure 3.1B). However, a 
common Rev-erbα cistrome included binding at clock genes in all tissues, 
consistent with its universal function in the core clock (Figure 3.1B) (Preitner et 
al., 2002; Bugge et al., 2012; Cho et al., 2012). 
 
RevDR2 and RORE were the most enriched motifs at Rev-erbα binding sites 
shared among tissues (Figure 3.1A), consistent with earlier reports that the 
function of Rev-erbα as a repressive component of the molecular clock involves 
binding to two RORE motifs that function in the transcriptional regulation of the 
Bmal1 gene (Yin and Lazar, 2005). Rev-erbα recruits the NCoR-HDAC3 complex 
to actively repress Bmal1 transcription (Yin and Lazar, 2005), and liver specific 
deletion of HDAC3 induced Bmal1 expression (Figure 3.2B) at ZT10, consistent 
with previous reports (Yin and Lazar, 2005; Feng et al., 2011). However, the loss 
of HDAC3 did not dampen circadian rhythmicity of Bmal1 nor other clock 
components as much as the loss of Rev-erbα itself, suggesting an additional 
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mechanism (Figure 3.2A, B).  
 
Another, non-mutually exclusive mechanism posits competition with the 
activating nuclear receptor ROR for the DNA binding site, which contains 
RevDR2/RORE motifs bound by both receptors (Forman et al., 1994; Giguere et 
al., 1994; Harding and Lazar, 1995). To determine target genes common to 
RORs and Rev-erbα, we compared gene expressions in livers depleted of RORα 
and g, at their peak time of expression, with gene expression from Rev-erbα 
knockout livers (9) (Figure 3.3A). Intriguingly, genes regulated both by Rev-erbα 
and the RORs included clock genes such as Bmal1, Npas2, Cry1, and E4bp4, 
and were expressed with large circadian amplitudes, consistent with the model 
that Rev-erbα and RORs are both critical regulators of the clock (Figure 3.3B). 
By contrast, Rev-erbα-specific genes had modest circadian rhythms and were 
enriched for liver metabolic processes (Figure 3.3C). 
 
Although RORa expression was similar at ZT10 and ZT22, there was a marked 
difference between RORa binding to ROREs at the clock genes Bmal1 and 
Npas2 at these times (Figure 3.4A). Deletion of Rev-erbα enhanced RORα 
recruitment to these sites at ZT10, and this was potentiated by loss of Rev-erbβ 
(Figure 3.4B), consistent with lower binding of RORα at ZT10 being due to 
competition with Rev-erbs. Conversely, hepatic overexpression of Rev-erbα 
reduced RORα recruitment to Bmal1 and Npas2 sites at ZT22 (Figure 3.4C). 
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Genome-wide, ~44% of RORα binding sites overlapped with Rev-erbα, and 
these were more likely to be circadian than RORα-specific sites (Figure 3.4D). 
Moreover, oscillating RORα binding sites were enriched near common target 
genes of RORs and Rev-erbα (Figure 3.4E), further suggesting that RORα and 
Rev-erbα compete for binding at highly circadian genes including core 
components of the molecular clock.  
 
3.3b Rev-erbα Binds to the Genome Using Both DBD-Dependent and DBD-
Independent Mechanisms 
To understand why Rev-erbα and ROR tended to compete near clock genes but 
not Rev-erbα-specific genes, we performed ChIP-exonuclease followed by high-
throughput sequencing (ChIP-exo) (Rhee and Pugh, 2011) in mouse liver at 
ZT10 to better resolve Rev-erbα binding. At clock genes that regulated by Rev-
erbα and RORs, exemplified by Bmal1 and Cry1, the RevDR2/RORE motif was 
detected at ChIP-exo peaks (Figure 3.5A, left). However, Rev-erbα ChIP-exo 
peaks were most commonly enriched for the motif bound by liver-lineage 
determining TF hepatocyte nuclear factor 6 (HNF6) (Figure 3.5B). As exemplified 
by Cyp2b13 and Slc45a3, these Rev-erbα binding sites co-localized with HNF6 
in mouse liver (Figure 3.5A, right). Overall, the HNF6 motif was found at 1,108 
Rev-erbα ChIP-exo sites (Figure 3.5C), the vast majority of which were also 
detected by HNF6 ChIP-exo in liver (Wang et al., 2014). Indeed, enhancer RNAs 
(eRNAs) at these sites bound by Rev-erbα and HNF6 had a robust circadian 
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expression pattern (Figure 3.5D), and were markedly up-regulated in livers 
depleted of Rev-erbα, indicating active repression of enhancer function at these 
sites (Figure 3.5E) (Fang et al., 2014). 
 
To test whether the binding of Rev-erbα on the genome can be indirect, we 
utilized a mouse model with a conditional deletion of the Rev-erbα DNA-binding 
domain (DBD). These mice have been previously studied as a model of Rev-
erbα deletion (Cho et al., 2012; Lam et al., 2013), but the targeting strategy is 
predicted to lead to in-frame deletion of the DBD (Figure 3.6A) and Rev-erbα 
immunoblot of mouse liver after Cre-recombination revealed an abundant 
species at the approximate molecular weight of the protein lacking the DBD 
(Figure 3.6B). The identity of this protein as full-length Rev-erbα lacking its DBD 
was confirmed by mass spectrometric analysis of Rev-erbα immunoprecipitates 
from recombined liver extracts (Figure 3.6C). Thus, this model is actually a 
knock-in of a DBD mutation, rather than a complete knockout of the Rev-erbα 
protein. We studied the function of this Rev-erbα DBD mutant in mice whose 
livers were also depleted of Rev-erbβ to eliminate its compensatory effects 
(Bugge et al., 2012; Cho et al., 2012).  
 
ChIP-seq analysis of Rev-erbα in livers expressing only the Rev-erbα DBD 
mutant ("DBDm") revealed a comparable level of binding at a subset of wild type 
sites ("DBD-independent sites"), while binding was dramatically reduced at many 
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other sites ("DBD-dependent sites") (Figure 3.7A, B). HNF6 ChIP-seq signals 
(Faure et al., 2012) were more enriched at Rev-erbα DBD-independent sites than 
at the DBD-dependent sites (Figure 3.7C), suggesting that HNF6 might tether 
Rev-erbα to the DNA even in the absence of Rev-erbα DBD domain. 
 
DBD-dependent sites were enriched in RORE as well as dimeric RevDR2 motifs, 
in agreement with direct DNA binding (Figure 3.7D). These motifs are also 
recognized by ROR, and indeed the binding of RORα at these sites decreased 
markedly at ZT10 when Rev-erbα competition is strongest (Figure 3.7E). 
RevDR2 were depleted in DBD-independent sites while ROREs still exist in a 
minority of sites (Figure 3.7D), suggesting RORE may facilitate, although not 
required for, DBD-independent binding. The HNF6 motif was markedly enriched 
at DBD-independent sites (Figure 3.7D), and Rev-erbα binding at Rev-
erbα/HNF6-exo sites was comparable between wild type and DBDm mice, 
following the same pattern as DBD-independent sites (Figure 3.7F). The 
simultaneous binding of Rev-erbα and HNF6 at these sites was confirmed by 
ChIP-re-ChIP experiments in wild type liver, whereas HNF6 and Rev-erbα were 
not co-localized at DBD-dependent sites (Figure 3.8A, B). Enhancer RNA 
transcription showed circadian oscillation in phase ZT22, at DBD-dependent and 
-independent sites (Figure 3.8C), suggesting active repression of Rev-erba in 
both cases. In agreement with Rev-erbα functioning by recruiting the corepressor 
complex, HDAC3 binding at Rev-erbα  sites was reduced in Rev-erb-depleted 
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livers (Figure 3.9A). In addition, the HDAC3 ChIP-seq signal in the DBDm was 
reduced at DBD-dependent sites but not at sites that are DBD-independent 
(Figure 3.9B), suggesting active repression by Rev-erbα via recruitment of 
HDAC3.  
 
3.3c HNF6 Motif is Required for Rev-erbα DBD-Independent Binding 
To determine whether HNF6 is required for Rev-erbα DBD-independent binding, 
we performed ChIP-seq for Rev-erbα in liver of 129S1/SvlmJ mice, and 
compared this result with that obtained in the C57BL/6J mice. The two strains 
differ by ~5.4 million single nucleotide polymorphisms (SNPs), and SNPs were 
predicted to cripple the HNF6 motif at 107 sites in C57BL/6J mice and 71 sites in 
129S1/SvlmJ mice. Remarkably, Rev-erbα binding was markedly diminished at 
the sites in which the SNPs disrupt either RevDR2/RORE or HNF6 motif in 
C57BL/6J or 129S1/SvlmJ mice (Figure 3.10A, B). Specific examples of strain-
dependent binding of Rev-erbα at HNF6 sites are shown in Figs. 3A-B, and 
differential binding in the two mouse strains was confirmed by ChIP-PCR for 
HNF6 and Rev-erbα (Figure 3.11A, B). Interestingly, while the HNF6 motif was 
most significantly associated with strain specific Rev-erbα binding by the same 
analysis, we also found significant association with motifs for several other TFs 
that play important roles in liver function, suggesting involvement of other 
partners in Rev-erbα binding in the absence of RORE and RevDR2 (Figure 
3.10C).  
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To further test the hypothesis that HNF6 could mediate Rev-erbα binding at the 
tethering sites, we induced hepatocyte-specific knockout of HNF6 in 10-week-old 
C57Bl/6 mice by tail vein injection of AAV8-Tbg-Cre into HNF6fl/fl mice, resulting 
in efficient deletion of HNF6 in the liver (Figure 3.12A). Loss of HNF6 leads to 
significant attenuation of Rev-erbα binding at the DBD-independent sites, which 
have been shown to co-localize with HNF6 by Rev-erbα-HNF6 ChIP-re-ChIP 
(Figure 3. 8A, B) in the previous results, while little effects were observed on the 
DBD-dependent sites (Figure 3.12B). Remarkably, among those tethering sites, 
Rev-erbα binding near metabolic targets that overlapped with HNF6 binding was 
significantly decreased, exemplified by Acacb and Cyp2b13 (Figure 3.12C). By 
contrast, direct binding of Rev-erbα was preserved at clock-related genes, 
exemplified by Bmal1 and Npas2 (Figure 3.12D). At the genome-wide level, 
HNF6 KO reduced a population of Rev-erbα binding sites (Figure 3.13A). These 
sites were highly enriched for the HNF6 motif (>85%), with no significant 
enrichment for other motifs (Figure 3.13B). 
 
3.3d DBD-Independent Rev-erbα Sites Regulate Metabolic Genes in Liver 
The preserved binding of HDAC3, mediated by Rev-erbα DBD mutant, at 
metabolic genes suggested that hepatic expression of these genes might also be 
intact relative to livers of mice in which the Rev-erbα protein is deleted. To test 
this, we compared the gene expression changes in mice lacking Rev-erbα in liver 
with published results using the DBDm mouse model used here, in which Rev-
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erbα is converted to the DBD mutant and Rev-erbβ is also deleted (Cho et al., 
2012). Circadian clock genes were derepressed in both situations, demonstrating 
that that regulation of these genes required direct binding at RevDR2/RORE sites 
by Rev-erbα. Overall only ~25% of Rev-erbα target genes that were de-
repressed in Rev-erbα KO mice were also de-repressed in the DBDm mice 
(“DBD-dependent Rev-erbα targets”) (Figure 3.14A). Genes de-repressed 
specifically in Rev-erbα KO mice (“DBD-independent Rev-erbα targets”) showed 
circadian expression peaking at ZT22 (Figure 3.14B), and were enriched for lipid 
metabolic functions (Figure 3.14C), suggesting that Rev-erbα regulates circadian 
lipid metabolic genes independent of its DBD. In support of this, DBD-
independent Rev-erbα/HDAC3 sites were enriched near DBD-independent Rev-
erbα targets, whereas DBD-dependent Rev-erbα/HDAC3 sites, where Rev-erbα 
and HDAC3 binding markedly reduced in DBDm mice, were more enriched near 
DBD-dependent Rev-erbα targets (Figure 3.14A). Examples of the deletion-
specific regulation of metabolic genes are shown in Figure 3.15A and B. 
Consistent with preserved metabolic gene expression in the DBDm mice livers, 
these mice did not display hepatosteatosis as is characteristic of the mice with 
complete deletion of Rev-erbα (Figure 3.15C, D, E) (Feng et al., 2011; Bugge et 
al., 2012). 
 
We further tested whether HNF6 depletion will also affect the hepatic lipid 
metabolism. Indeed, the loss of HNF6 resulted in fatty liver, demonstrated by Oil 
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Red O staining (Figure 3.16A), with marked accumulation of hepatic triglycerides 
in mice fed on chow diet and exacerbation of high fat-diet HFD-induced steatosis 
(Figure 3.16B). Consistent with our hypothesis and the hepatosteatotic 
phenotype, many lipogenic genes repressed by Rev-erbα and its co-
repressor/HDAC3 complex, including Lpl, Scd1, Acacb, Cd36, Fasn (Feng et al., 
2011; Bugge et al., 2012; Sun et al., 2012; Sun et al., 2013) were up-regulated in 
the HNF6 KO liver (Figure 3.16C). To test whether the regulation of lipid 
metabolism by HNF6 and Rev-erbα involved a common pathway, we performed 
microarray analysis with HNF6 KO liver from mice fed chow diet. Using a cut-off 
of >1.5-fold change and p-value <0.05, we identified 101 up-regulated genes and 
80 down-regulated genes. The up-regulated genes were enriched for oxidation-
reduction, lipid biosynthesis, lipid storage and other metabolic processes and the 
down-regulated genes included inflammatory genes and monosaccharide 
metabolic genes (Figure 3.17A).  Notably, gene set enrichment analysis (GSEA) 
showed that up-regulated genes in HNF6 KO liver were over-represented by the 
genes up-regulated in Rev-erbα KO liver (Figure 3.17B). Moreover, the lipid 
metabolic genes were enriched in the genes up-regulated commonly in both 
HNF6 and Rev-erbα KO (Figure 3.17C), while the circadian clock genes were 
enriched in genes exclusively up-regulated in the Rev-erbα KO (Figure 3.17D), 
consistent with the hypothesis that HNF6 tethered Rev-erbα is targeted to 
metabolic genes but not the clock genes. 
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3.4 Discussion and Future Directions 
These findings demonstrate that Rev-erbα has a DBD-independent function that 
contributes to its regulation of liver metabolism. Other nuclear receptors, 
including estrogen receptor and glucocorticoid receptor, have DBD-independent 
activities through protein-protein interactions with other TFs, either directly or 
indirectly (Glass and Saijo, 2010; Faure et al., 2012). In liver, Rev-erbα is 
tethered to chromatin by hepatic lineage determining TFs (Figure 3.18), and this 
mechanism of binding explains much of the non-overlapping cistromes of Rev-
erbα in different tissues as well as the large proportion of binding sites without 
the RevDR2/RORE motif. In liver, the tethered cistrome is more enriched for 
genes with specialized function in hepatic metabolism, whereas the DBD-
dependent cistrome is enriched for circadian clock genes and common to 
multiple tissues. 
 
Circadian clocks and metabolism are tightly connected (Feng and Lazar, 2012), 
and Rev-erbα has emerged as a transcriptional link from circadian rhythms to 
metabolism in multiple tissues (Everett and Lazar, 2014). Our findings delineate 
a molecular hierarchy that governs how the clock is wired with metabolism. Direct 
competition between Rev-erb and ROR provides a universal mechanism for self-
sustained control of molecular clock across all tissues. On top of this basic 
landscape, circadianly expressed Rev-erb utilizes lineage-determination factors 
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to convey a tissue-specific epigenomic rhythm that, through corepressor and 
HDAC3, regulates metabolism tailored to the specific need of that tissue. These 
two modes of action may bestow on Rev-erbα the ability to stabilize the circadian 
oscillations of clock gene, while coupling liver metabolism to environmental and 
metabolic changes, perhaps through its endogenous ligand heme (Yin et al., 
2007). This raises the possibility that synthetic ligands which specifically affect 
Rev-erbα interaction with NCoR/HDAC3 without disrupting DNA-binding could 
modulate liver metabolism with lesser effects on the integrity of the circadian 
clock.  
 
While the mechanisms of Rev-erβ regulation of liver circadian metabolism have 
been elucidated, how ROR contribute to the liver metabolism regulation still 
remains to be shown, which will be addressed in the next chapter.  
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Figure 3.1 Overlap of Rev-erbα  cistrome in various tissues are limited. (A) Overlap of Rev-
erbα cistromes in liver (9), brain and epididymal adipose tissue (eWAT). Most significantly 
enriched known motifs (abundance>10%) in common and tissue specific cistromes are shown. (B) 
GO analysis of different group of binding sites. 
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Figure 3.2 HDAC3 does not dampen circadian rhythmicity of clock genes. 
mRNA expression of Bmal1, Cry1, and E4bp4 over a 24-hour period in (A) wild 
type, Rev-erbα knockout and (B) HDAC3 KO mouse liver. The expression at 
ZT10 is highlighted in the upper right corner of the plot. Data are expressed as 
mean± SEM (* Student’s t-test, p < 0.05, n= 4 or 5 per group).  
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Figure 3.3 Common direct targets of Rev-erbα and RORs are enriched for 
the clock genes. (A) Heat map showing expression fold changes of genes 
deactivated by RORα/γ double KO (DKO/WT< -1.3, p<0.01) and derepressed by 
Rev-erbα KO (aKO/WT>1.3, p<0.01). (B) Mean relative GRO-seq transcription 
(left) throughout 24-hour light dark cycle, as well as oscillation amplitudes (right) 
of RORs/Rev-erbα common targets (red) and Rev-erbα specific targets (blue). 
Time points were duplicated for clearer visualization.  (C) GO analysis of the 
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genes that are commonly regulated by Rev-erbα and RORs, and the genes that 
are specifically regulated by Rev-erbα.    
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Figure 3.4 Rev-erbα and RORα  compete for binding at highly circadian 
genes including core components of the molecular clock. (A) ChIP-PCR 
validation of cyclic RORα binding at clock genes promoters at ZT10 or ZT22 in 
wild type mice liver, in comparison with an unbound control at Arbp. Data are 
expressed as mean± SEM (Student’s t-test, *p<0.05, n=4). (B) RORα binding at 
clock and control genes promoters at ZT10, in wild type (WT), Rev-erbα KO 
(aKO), Rev-erbβ knockdown (bKD), and aKO/bKD mice liver, interrogated by 
ChIP-PCR. Data are expressed as mean± SEM (* Student’s t-test, p<0.05, n=4). 
(C) RORα binding at clock and control genes promoters at ZT10 or ZT22 in Rev-
erbα overexpression mice liver, interrogated by ChIP-PCR. Data are expressed 
as mean± SEM (* Student’s t-test, p<0.05, n=6 or 7). (D) Circadian binding of 
 52 
RORα at sites overlapped or not overlapped with Rev-erbα cistrome (N.S. 
Student’s t-test, p>0.05). (E) Percentage of common or Rev-erbα specific target 
genes containing high confidence oscillating RORα binding sites (ZT22>2 reads 
per million (rpm), ZT22/ZT10>1.5) within 50kb of TSSs (P value from 
hypergeometric test).  
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Figure 3.5 Rev-erbα ChIP-exo peaks are enriched for HNF6 motif. (A) 
Genome browser view of Rev-erbα and HNF6 ChIP-exo signals under Rev-erbα 
ChIP-seq peaks near clock and metabolic genes. Blue bars indicate locations of 
RevDR2/RORE and HNF6 motif. (B) Highly enriched known motifs found in Rev-
erbα ChIP-exo peak pairs 22-26bp apart. (C) Heat map showing 5’-end tag 
densities of Rev-erbα ChIP-exo centered at HNF6 motifs within 1,108 peak pairs. 
Red and blue indicate tag density on the plus and minus strand, respectively. (D) 
Mean relative eRNA transcription (22) at Rev-erbα/HNF6-exo sites throughout 
24-hour light dark cycles. Data were double plotted for clearer visualization. (E) 
eRNA tag density (22) centered at Rev-erbα/HNF6-exo sites near Rev-erbα 
target genes, in Rev-erbα KO and wild type liver.  
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Figure 3.6 Conditional Rev-erbα allele deletion results in an in-frame DNA 
binding domain mutant (DBDm). (A) Illustration depicting floxed exons 3 and 4 
encoding the DNA binding domain of the Rev-erbα locus. Numbers highlighted in 
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red represent the nucleotide codon phases at exon-exon junctions. Deletion of 
exons 3 and 4 maintains the open reading frame through splicing of exon 2 to 
exon 5. The peptide sequence highlighted (from S6C) is unique to the conditional 
Rev-erbα DBDm, with amino acids encoded in exons 2 and 5 colored black and 
red respectively. (B) Western blot of Rev-erbα in the livers of wild type mice, 
Rev-erbα KO mice, wild type control mice (floxed mice injected with AAV-GFP), 
and DBDm mice (floxed mice injected with AAV-Cre), “*” denotes non-specific 
band. (C) Rev-erbα peptides detected by mass spectrometry in wild type control 
and the DBDm livers. Red arrows indicate peptides discovered in wild type control 
liver mapping to the DNA binding domain of Rev-erbα, which are absent in the 
DBDm. The blue arrow indicates a unique peptide found only in the DBDm livers 
as a result of the new open reading frame joining exons 2 and 5. Note the third 
threonine (amino acid 203) of the highlighted DBDm peptide is a 1 amino acid 
substitution from alanine resulting from the new exon splice junction between 
exons 2 and 5.  
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Figure 3.7 Rev-erbα binds to the genome using both DBD-dependent and 
DBD-independent mechanism. (A) Heat map showing Rev-erbα ChIP-seq tag 
densities (at ZT10) in wild type, DBD mutant (DBDm), and Rev-erbα KO (aKO) 
mice, at DBD-dependent and -independent sites identified among 5,792 high 
confidence Rev-erbα peaks (peak height >1rpm, WT/Rev-erbα KO>3). (B) 
Binding strength of Rev-erbα at selected DBD-dependent and DBD-independent 
sites at ZT10 as determined by ChIP-PCR. Data are expressed as mean±SEM (* 
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Student’s t-test, p < 0.05, n=4 per group). (C) HNF6 tag density at Rev-erbα 
DBD-dependent and -independent sites. (D) The percent of sites containing 
RevDR2, RORE, or HNF6 motif in DBD-dependent sites and DBD-independent 
sites (*** hypergeometric test p<1e-3). (E) Circadian binding of RORα at Rev-
erbα DBD-dependent sites but not DBD-independent sites (*** Student’s t-test 
p<1e-3). (F) Difference in Rev-erbα binding strengths between WT and DBDm 
mice at three groups of binding sites.  
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Figure 3.8 Rev-erbα and HNF6 co-localize at the functional DBD-
independent sites. (A) Sequential ChIP of Rev-erbα followed by either HNF6 or 
IgG ChIP in wild type and DBDm mouse liver at ZT10. Data are expressed as 
mean± SEM (* Student’s t-test, p<0.05, n=3 or 4 per group). (B) Sequential ChIP 
of HNF6 followed by either Rev-erbα or IgG ChIP in wild type and DBDm mouse 
liver at ZT10. Data are expressed as mean±SEM (* Student’s t-test, p<0.05, n=3 
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or 4 per group).  (C) eRNA oscillation at DBD-dependent sites and DBD-
independent sites throughout 24-hour light dark cycle. Time points were 
duplicated for better visualization.  
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Figure 3.9 HDAC3 binding at the DBD-independent sites is attenuated in the 
Rev-erbs depleted mice while not affected in the DBDm. (A) Comparison of 
HDAC3 binding in WT and Rev-erb αKO/βKD mice at DBD-dependent and DBD-
independent Rev-erbα sites (*** Student’s t-test p<1e-3). (B) Binding of HDAC3 
at DBD-dependent and -independent sites in WT and DBDm liver (N.S. Student’s 
t-test, p>0.05, *** Student’s t-test p<1e-3) .  
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Figure 3.10 SNP associated strain-specific occupancy suggests HNF6-
mediated binding of Rev-erbα. (A) Heat map showing log2 fold changes of 
Rev-erbα binding in 129 and B6 mice. The left column in the heat map contains 
141 Rev-erbα peaks where RevDR2/RORE motif scores are higher in 129 mice 
and lower in B6 mice, due to the SNPs (illustrated in the left panel). Similarly, the 
right column contains 101 SNP-bearing Rev-erbα peaks with better 
RevDR2/RORE in the B6 genome. P value was calculated using Student’s t-test. 
(B) Same analysis as in A, focusing on SNPs disrupting HNF6 motif under Rev-
erbα peaks. (C) Heat map showing -log10 p values for other motifs that are 
enriched in DBD-independent Rev-erbα peaks.  
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Figure 3.11 Binding strength of Rev-erbα in C57BL/6J and 129S1/SvlmJ. (A-
B) Binding strengths of HNF6 (A) and Rev-erbα (B) are correlated with HNF6 
motif at selected Rev-erbα sites at ZT10, as determined by ChIP-PCR. Data are 
expressed as mean± SEM (* Student’s t-test, p < 0.05, n=4 per group).  
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Figure 3.12 HNF6-tethered Rev-erbα binding near metabolic genes is 
decreased in HNF6-KO liver. (A) Western blot for HNF6 of total liver lysates 3 
weeks after AAV injection. GFP, treatment with AAV-Tbg-GFP; Cre, treatment 
with AAV-Tbg-Cre, b-Tubulin was used as a loading control. (B) Binding strength 
of Rev-erbα at selected DBD-independent and DBD-dependent sites at ZT10 as 
validated by ChIP-PCR. Data are expressed as mean±SEM (* Student’s t-test, p 
< 0.05, n=4 per group). (C) and (D) Genome browser view of Rev-erbα ChIP-seq 
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peaks in the widltype control and HNF6 KO liver, and HNF6 ChIP-seq peaks 
near (C) metabolic genes Acacb and Cyp2b13, and (D) clock genes Bmal1 and 
Npas2. The Rev-erbα peaks that overlapped with HNF6 peaks and Rev-erbα 
DBD-dependent binding sites are highlighted.  
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Figure 3.13 Sites with reduced Rev-erbα binding in the HNF6 KO are 
enriched for HNF6 motif. (A) Scatterplots of the Rev-erbα high confidence 
cistrome in the wildtype control (x-axis) and HNF6 KO (y-axis). The cut-off for 
differentially regulated sites is fold change >3. The down-regulated sites are 
plotted in red, and no up-regulated sites were found. (B) Enrichment of HNF6, 
HNF4A, CEBP, FOXA1, DR2 and RORE motif in the down-regulated sites and 
unchanged sites.  
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Figure 3.14 Genes regulated exclusively in Rev-erbα KO are enriched for 
metabolic process. (A) Top panel shows the number of DBD-dependent and -
independent Rev-erbα target genes identified using microarrays in Rev-erbα KO 
and DBDm mice. Bar graph shows ratios of DBD-independent and -dependent 
Rev-erbα/HDAC3 binding sites located near two groups of Rev-erbα target 
genes. (B) Circadian average mRNA expression of Rev-erbα DBD-dependent 
and -independent target genes mRNA levels throughout 24-hour cycle were 
normalized to the peak expression of the day. Time course microarray data from  
were duplicated for better visualization. (C) Gene ontology analyses for Rev-erbα 
DBD-dependent and -independent target genes.  
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Figure 3.15 DBD-independent Rev-erbα sites regulate metabolic genes in 
liver. (A) mRNA expression of lipid metabolic genes normalized to Arpp, 
measured by RT-qPCR, in livers of Rev-erbα KO mice and wild type mice at 
ZT10. (B) mRNA expression of lipid metabolic genes normalized to Arpp, 
measured by RT-qPCR, in livers of Rev-erbα DBDm (Rev-erbα/β double floxed 
mice injected with AAV-Tbg-Cre) or control mice (floxed mice injected with AAV-
Tbg-GFP) at ZT10. Data are expressed as mean± SEM (* Student’s t-test, 
p<0.05, n=4 per group). (C) Hepatic triglyceride (TG) levels in the same mice as 
in B. (D) Hepatic TG levels in mice as in C (* Student’s t-test, p<0.05, n=4 per 
group). (E) Oil Red O staining of livers from wild type control mice (Rev-erbα/β 
floxed mice injected with AAV-GFP), and DBDm mice (Rev-erbα/β floxed mice 
injected with AAV-Cre).  
 69 
 
Figure 3.16 Liver-specific depletion of HNF6 in adult mice causes 
hepatosteatosis. (A) Oil Red O staining of livers from the control mice and 
HNF6 KO mice fed on normal chow diet at a magnification of 20X. (B) Hepatic 
triglyceride (TG) measurement of the livers from the control mice and HNF6 KO 
mice fed on normal chow diet and high fat diet (HFD). mg per g, mg triglyceride 
per g of liver weight. Data are expressed as mean±SEM (* Student’s t-test, p < 
0.05, n=3 per group for chow diet, n=7 per group for HFD). (C) Relative mRNA 
expression level of lipid metabolic genes known to be Rev-erbα and HDAC3 
targets in the control and HNF6 KO mice. Data are expressed as mean±SEM (* 
Student’s t-test, p < 0.05, n=4 per group).  
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Figure 3.17 HNF6 and Rev-erbα regulate hepatic lipid metabolism through 
common pathways. (A) Heatmap and gene ontology (GO) analysis of 
differentially regulated genes in the HNF6 KO.  (B) GSEA results for the 
enrichment of genes up-regulated by HNF6 KO in Rev-erbα KO liver. (C) and (D) 
Gene ontology (GO) analysis of the (C) genes up-regulated in both HNF6 KO 
and Rev-erbα KO liver and (D) genes up-regulated exclusively in Rev-erbα KO.  
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Figure 3.18 Model depicting distinct mechanisms of Rev-erbα regulating 
clock and metabolic genes in liver. Grey refers to other potential TFs that may 
be involved in the tethering of Rev-erbα. 
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CHAPTER 4 
Redundant Regulation of Circadian Hepatic Metabolism by 
RORα  and RORγ  
 
 
 
 
The text, figures, and legends in this chapter were the work of Yuxiang Zhang 
with the following exceptions. Romeo Papazyan provided the SCAP liver specific 
deletion samples and performed the Srebp1c western blot experiments. Bin Fang 
and Manashree Damle assist with the bioinformatics analysis. Jennifer Jager 
performed the GRO-seq experiments. Dan Feng assisted with the RORs ChIP-
seq experiment. Zheng Sun assisted with the metabolic assays in RORs liver 
specific deletion mice.   
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4.1 Abstract 
The liver circadian clock is tightly connected to metabolism. Although the liver 
clock is entrained by the central clock, it also directly controls metabolic gene 
expression. Hormone responsive nuclear factors are hypothesized to be the 
major clock components that regulate metabolism. Here, we investigate the 
circadian regulation of hepatic metabolism by nuclear receptors RORα and 
RORγ.  RORα and γ double depletion was induced by tail-vein injection of AAV-
TBG-Cre into adult RORαfl/flγfl/fl mice. Mice were assayed for lipid triglyceride and 
expression of genes involved in lipogenesis. Transcriptional mechanisms of the 
regulated genes were investigated by global run-on assay followed high-
throughput sequencing (GRO-seq). We discovered that hepatic depletion of 
RORs increased expressions of genes involved in lipogenesis as well as the 
hepatic triglyceride levels, specifically at ZT22 (5 AM) and during feeding, but not 
at ZT10 (5 PM) nor during fasting. GRO-seq analysis suggested that regulation 
of lipid metabolism by RORs was mediated by SREBP1-c. Indeed, ROR 
depletion significantly up-regulated nuclear SREBP1-c protein level specifically at 
ZT22. Overall, our study reveals a time-specific regulation of liver lipid 
metabolism by RORs, and suggests a potential role of chronotherapy targeting 
circadian factors in the treatment of metabolic disorders. 
 
 74 
4.2 Introduction 
In Chapter 3, we showed that Rev-erbα modulates the clock and metabolism by 
different genomic mechanisms. Clock control requires Rev-erbα to bind directly 
to the genome at its cognate sites, where it competes with activating ROR TFs. 
By contrast, Rev-erbα regulates metabolic genes primarily by recruiting the 
HDAC3 corepressor to sites to which it is tethered by cell type-specific 
transcription factors. However, clock could control the hepatic metabolism not 
only through Rev-erbs, but also through other factors, such as its closely related 
nuclear receptors RORs. RORs could compete with Rev-erbs for common 
binding and maintain the circadian rhythm of target genes, and could also 
regulate other metabolic processes at different phases. Therefore, in this chapter, 
we aim to address the mechanism of RORs regulation of hepatic metabolism.  
 
ROR has three members, RORα, RORβ, and RORγ. Among them, only RORα 
and RORγ are highly expressed in the liver, while RORα are mainly expressin 
the central nervous system. As nuclear receptors, RORs also are composed of 
N-terminal activation domain (AF1), a DNA-binding domain (DBD), a central 
hinge region, and a C-terminal ligand-binding domain (LBD). But unlike Rev-erbs, 
RORs possess the ligand-dependent activation function domain (AF2) which 
allows it to interact with coactivators to activate target transcription. 
 
The role of RORs regulation of hepatic metabolism has been investigated before.  
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RORα and RORγ could also regulate liver lipid, bile acid, and glucose pathway, 
but maybe through different pathways compared to Rev-erb regulation. It has 
been reported that RORγ could regulate rhythmic expression of several lipid 
metabolic genes, including the Insig2a, Elovl3 and Cyp8b1, by enhancing their 
expression at ZT20-4 (Takeda et al., 2014b). In addition, both RORα and RORγ 
deficient mice exhibited decreased gluconeogenesis and improved insulin 
sensitivity and glucose tolerance during daytime specifically (Takeda et al., 
2014a; Kadiri et al., 2015). However, reports on RORα regulation of hepatic 
triglyceride are not consistent. While some studies report RORα deficient 
staggerer mice had a decreased serum and liver triglycerides and lipogenic gene 
expression (Lau et al., 2008; Kang et al., 2011), some others reported it had 
increased liver triglyceride accumulation and lipogenic gene expression (Wada et 
al., 2008). The differences in the experimental settings such as euthanizing time 
or feeding status at the time of euthanizing might be the factors that caused that 
inconsistency. In this study, we aim to elucidate the RORs regulation of hepatic 
lipid metabolism and address the mechanism of RORs regulation of their target 
genes in the mice deficient for RORs in the liver. 
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4.3 Results 
4.3a RORα and RORγ  Redundantly Regulate Clock Genes and Metabolic 
Genes 
RORα, RORγ and RORs double deletion were induced by injecting AAV-Tbg-Cre 
in RORαfl/fl or RORγfl/fl or double floxed mice. The depletion of RORs was 
confirmed by qRT-PCR (Figure 4.1A). Notably, RORs targeted clock genes 
Bmall1 and clock were only significantly regulated in the double mutant mice 
(Figure 4.1B), suggesting redundant function of clock gene regulation of RORα 
and γ. Interestingly, it is also found that several lipid metabolic genes including 
Acacb, Fasn, Elovl6, Gpam and Acly were also under redundant regulation of 
RORα and RORγ (Figure 4.1C). To systematically analyze the function of RORα 
and RORγ in the mice liver, we compared the microarray heatmaps of single 
mutant and double mutant mice liver. Consistent with previous results, double 
mutant mice liver exhibited significant regulation of RORs target genes, while few 
genes were regulated in the single mutant liver (Figure 4.2A). Among the down-
regulated are some of the well-known ROR target genes, including Bmal1, Cry1, 
Npas2, Cyp8b1 and others, those genes were enriched for circadian rhythm 
(Figure 4.2B). The up-regulated genes include Srebf1 and some other genes 
regulated by Srebp1c, including Fasn, Scd1, Elovl6, Acly (Figure 4.2A). Gene 
ontology analysis of those genes showed enrichment for fatty acids metabolism 
and PPAR signaling pathway, suggesting a that RORs might be involved in the 
regulation of hepatic lipid metabolism.  
 77 
To further confirm the functional redundancy of RORα and RORγ in the liver, we 
profiled their cistrome by ChIP-seq analysis. It is found that most of the RORα 
and RORγ binding sites overlapped (Figure 4.3A), and the gene near the 
overlapping sites were over-represented by circadian rhythm, insulin signaling 
pathway, and other metabolic pathways (Figure 4.3B), which are consistent with 
its regulation of clock genes and Srebp1c pathway. Example of RORα and RORχ 
binding were shown in Figure 4.3C, where RORα and RORγ bind to the same 
sites that disappeared in the RORs double mutant mice livers.  
 
4.3b RORα and RORγ  Liver Specific Deletion Leads to Accumulated 
Triglycerides Level and Dysregulation of Lipid Metabolic Genes at ZT22 
Based on the microarray analysis, we characterized the lipid metabolism in the 
RORs double mutant mice. We observed a trend of increase in hepatic 
triglycerides in RORs double mutant mice fed on chow diet, and more significant 
increase in mutant mice fed on 6-week high fat diet (Figure 4.4A), which was 
confirmed by the Oil Red O staining (Figure 4.4B).  
 
To elucidate the mechanism of RORs regulation of the circadian rhythm of lipid 
metabolic genes, we harvested the mice liver every 4 hours and the circadian 
expression of the lipid metabolic genes repressed by RORs identified from 
microarray. Interestingly, it is found that the up-regulation of those genes are 
restricted to ZT18~ZT26 (Figure 4.5), suggesting those genes are regulated by 
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RORs only during this time window, and are dominantly regulated by other 
factors outside this time frame.  
 
4.3c RORs Regulation Is Specific to Ad Lib Fed Mice But Not Fasted Mice 
Since feeding behavior is tightly regulated by the circadian clock and have a 
robust rhythm (Turek et al., 2005), we further investigate the feeding or fasting 
status of the mice would affect RORs regulation of those metabolic genes. To 
address this, we harvest the mice either on ad lib feeding condition or fasting for 
16 hours (Figure 4.6A) after 6 weeks of high fat diet. We found the difference in 
hepatic triglycerides was diminished after fasting in mice (Figure 4.6B). Similarly, 
RORs regulation of Srebf1 and targets genes of Srebp1c was also minimized in 
the fasted mice (Figure 4.6C), suggesting RORs regulation of this pathway 
requires feeding and a robust Srebp1c signaling. 
 
4.3d RORs Regulate Liver Lipid Metabolism Through SREBP pathway 
To further characterize the mechanism of regulation of genes differentially 
expressed in RORs mutant mice, we performed the global run-on assay to 
measure the nascent transcription from the gene body and enhancers (eRNAs). 
As a result, we identified 541 up-regulated eRNAs and 762 down-regulated 
eRNAs (Figure 4.7A). Motif analysis showed that the down-regulated eRNAs 
were enriched for STAT1 motif and nuclear receptor motif including RORE, 
consistent with the canonical role of RORs as transcription activators. Notably, 
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the up-regulated eRNAs were enriched for Zinc Finger, and bHLH motif, which 
include the SREBP1 motif (Figure 4.7B). Therefore, we hypothesized that RORs 
regulated the hepatic lipid metabolism through an SREBP1c-dependent 
mechanism.  
 
In the wild type mice, it is observed that SREBP1c target genes expression has a 
circadian rhythm that peaks around ZT14~18. To further validate our hypothesis 
that RORs directly regulate clock genes and indirectly repress lipid metabolic 
gene, we interrogated the phase distribution of the eRNAs down-regulated or up-
regulated in RORs mutant mice liver. As shown in Figure 4.8A and B, the down-
regulated eRNAs were enriched around phase ZT21-24, while the up-regulated 
eRNA were enriched around phase ZT15-18, consistent with the phase of the 
clock genes directly regulated by RORs (ZT21-24), such as Npas2, and the 
phase of lipid metabolic genes regulated by Srebp1c (ZT15-18), such as Thrsp 
(Figure 4.8C). As expected, RORs deficient liver has elevated level of active form 
of Srebp1c in the nuclear (Figure 4.9A). However, the precursor form of Srebp-1c 
expression and mRNA level remained unchanged in RORs deficient liver, 
indicating that the regulation of Srebp-1c was more like on the post-translational 
level (Figure 4.9A, B). Indeed, it is found that Insig2, which can block Srebp1c 
signaling by retaining the Scap-Srebp1c complex in the ER, was directly 
activated by RORs, with strong RORs binding sites near the Insig2 transcription 
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start site (Figure 4.9C, D), suggesting RORs might repress the Srebp1c signaling 
by activating Srebp1c repressor Insig2 expression.  
  
4.4 Discussion and Future Directions 
 
Studies in RORα or RORγ null mice have suggested a role of RORs in the 
control of energy homeostasis and the regulation of lipid and glucose metabolism. 
However, since the regulation of energy and metabolism homeostasis is a 
complex process that involves multiple interrelated pathways in many organs 
involving endocrine, immune, and nervous systems, as well as the circadian 
clock and gut microbiome, it is difficult to determine whether the metabolic 
changes observed in ROR-deficiency mice are direct regulation of RORs or a 
result of systematic changes. Therefore, our study could elucidate the tissue 
specific function of RORs in the liver.  
 
Previous report on RORs regulation of liver metabolism using the RORs total 
body deficient mice has generated contradicting results. Some studies reported 
decreased while others reported increased hepatic triglyceride level in the RORα 
deficient staggerer mice, which suffered from deficient in cerebellum 
development (Lau et al., 2008; Kang et al., 2011; Wada et al., 2008). RORg null 
mice also displayed down-regulation of several lipid metabolic genes, but 
paradoxically, the nuclear active form of SREBP-1c also got significantly up-
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regulated, which is usually associated with up-regulation of lipogenic process 
(Takeda et al., 2014b).  Here, we showed that RORs regulation of lipid 
metabolism varies depending on the time of the day as well as the feeding status. 
Around ZT22, it could repress the lipid metabolic process through inhibition on 
the SREBP pathway while the mice were fed. But around ZT10 or during fasting, 
its regulation on the lipid metabolism is diminished, or reversed by indirectly 
impact through activation of clock genes.  
 
SREBP activities are regulated on both transcriptional and post-translational level. 
SREBP is regulated by LXR transcriptionally. Then, newly synthesized SREBPs 
are inserted into the endoplasmic reticulum (ER) membrane as inactive 
precursors, where it binds to the sterol-sensing protein SREBP cleavage 
activating protein (SCAP). Upon activation such as insulin signaling, SREBP-
Scap complex traffics to the Golgi via COPII vesicles where SREBP N-terminal 
bHLH-LZ transcription factor domain is cleaved and translocate into the nuclei as 
active form to control target gene transcription. Insig proteins, including Insig1 
and Insig2 are endoplasmic reticulum proteins that block the processing of 
SREBP by binding to SCAP, and thus prevent SCAP from escorting SREBPs to 
the Golgi. In our study, we found that RORs activate expression of Insg2 in the 
liver specifically around ZT22, and thus indirectly inhibit SREBP activity at that 
time.  
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To further validate this discovery, we will delete the RORs genes in the liver of 
the SCAP liver-specific deficient mice, by breeding their LoxP sites together, to 
test the dependence of RORs regulation of lipid genes on the SREBP signaling 
pathway. We expected in the absence of SCAP, RORs would no longer repress 
the expression of those lipid metabolic genes.  We will also try to over-express 
Insig2 gene by AAV vector in the RORs deficient liver, to test whether it could 
restore the expression of lipid genes back to normal level.  
 
 
  
 83 
 
Figure 4.1 RORα and RORγ  are redundant in regulating expression of clock 
genes and metabolic genes. Ratio of gene expression in Cre over GFP for (A) 
RORα and RORγ,(B) clock genes Bmal1 and Cry1, and (C) lipid metabolic genes 
including Acacb, Fasn, Elovl6, Gpam, Acly in RORs single or double mutant liver.  
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Figure 4.2 Transcriptome analysis of RORs single and double mutant mice 
liver. (A) Heatmap of the ROR single mutant and double mutant. The color 
indicate the log2 fold change ratio of Cre/GFP.  The cut-off used here is fold 
change over 1.3 with 15% FDR. (B) Gene ontology analysis of the down-
regulated genes and up-regulated genes. 
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Figure 4.3 Comparison of liver RORα and RORγ  cistromes. (A) Scatter plot of 
RORα and RORγ ChIP-seq signals. All the binding sites have been filtered by the 
KO sample (KO/WT>3). (B) Gene ontology analysis of the genes closest to the 
binding sites. (C) Screenshot of the RORα and RORγ binding sites near the well 
characterized target genes of RORs in the WT samples and KO samples. 
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Figure 4.4 RORs liver specific depletion leads to accumulated triglycerides 
after 6 week high fat diet. (A) Hepatic triglyceride measurement of the liver from 
the control mice and RORs mutant mice fed a normal chow diet and 6-weeks 
high fat diet. (mg/g) Milligrams of triglycerides per gram of liver weight. (B) Oil 
Red O staining of livers from the control mice and RORs mutant mice fed 6-
weeks high fat diet at a magnification of 20×.  
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Figure 4.5 RORs regulation of lipid metabolic genes are restricted around 
ZT 22. mRNA expression of Fasn, Acly, Acacb, and Spot14 over a 24-hour 
period in wild type and RORs mutant mouse liver. Data are expressed as 
mean±SEM. RU, relative unit after normalized to housekeeping gene Arbp 
mRNA expression  
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Figure 4.6 RORs regulation of lipid metabolic genes are restricted to fed 
mice but not to fasted mice at ZT22. (A) Feeding schedule before the mice 
dissection. (B) Hepatic triglyceride measurement of the liver from the fed and 
fasted control mice and RORs mutant mice fed on 6-weeks high fat diet. (mg/g) 
Milligrams of triglycerides per gram of liver weight. (C) mRNA expression of lipid 
metabolic genes at ZT22 normalized to Arbp, measured by RT-qPCR, in fed or 
fasted mice.  
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Figure 4.7 Differentially expressed nascent transcripts in RORs mutant 
mice liver. (A) Scatter plot of eRNAs tag count in WT and RORs mutant mouse 
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liver. Differentially expressed eRNAs are marked by different colors. (B) De novo 
motif analysis of the down-regulated and up-regulated eRNAs.  
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Figure 4.8 Up-regulated and down-regulated eRNAs were enriched in 
different phase. (A) Fraction of eRNA in each circadian phase that up-regulated 
in RORs double mutant liver. (B) Fraction of eRNA in each circadian phase that 
down-regulated in RORs double mutant liver. (C) Genome browser view of 
circadian eRNA transcription near the TSS of Naps2 and Thrsp in the wild type 
mice, and their regulation in WT and RORs mutant mice at ZT22.  
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Figure 4.9 RORs repress nuclear Srebp1c level by activating Insig2 
expression around ZT22. (A) Western blot of precursor Srebp1c, active form of 
nuclear Srebp1c, and loading control Pol II in the liver of RORs floxed mice 
injected with AAV-GFP or AAV-Cre, harvested at ZT22 or ZT10. (B) mRNA 
expression of Srebf1 at ZT22 and ZT10.  (C) mRNA expression of Insig2 over a 
24-hour period in wild type and RORs mutant mouse liver. (D) Genome browser 
view of RORa and RORg binding near the Insig2 TSS.    
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CHAPTER 5 
Future Directions 
 
 
 
 
 
 
The text, figures, and legends in this chapter were the work of Yuxiang Zhang 
with the following exceptions. Zheng Sun assisted with the metabolic assays in 
ultradian mouse model and performed the Oil Red O staining in those mice.   
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5.1 Summary 
Through the dissertation, we explored the mechanisms of circadian regulation of 
hepatic metabolism by nuclear receptors Rev-erbs and RORs. In Chapter 3, we 
showed that Rev-erbα modulates the clock and metabolism by different genomic 
mechanisms. Clock control requires Rev-erbα to bind directly to the genome at 
its cognate sites, where it competes with activating ROR TFs. By contrast, Rev-
erbα regulates metabolic genes primarily by recruiting the HDAC3 corepressor to 
sites to which it is tethered by cell type-specific transcription factors.  Thus, direct 
competition between Rev-erbα and ROR TFs provides a universal mechanism 
for self-sustained control of molecular clock across all tissues, whereas Rev-erbα 
utilizes lineage-determining factors to convey a tissue-specific epigenomic 
rhythm that regulates metabolism tailored to the specific need of that tissue. 
 
In Chapter 4, we discovered that hepatic depletion of RORs increased 
expressions of genes involved in lipogenesis as well as the hepatic triglyceride 
levels, specifically at ZT22 (5 AM) and during feeding, but not at ZT10 (5 PM) nor 
during fasting. GRO-seq analysis suggested that regulation of lipid metabolism 
by RORs was mediated by SREBP1-c. Indeed, ROR depletion significantly up-
regulated nuclear SREBP1-c protein level specifically at ZT22. Overall, our study 
reveals a time-specific regulation of liver lipid metabolism by RORs, and 
suggests a potential role of chronotherapy targeting circadian factors in the 
treatment of metabolic disorders. 
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5.2 Future Directions 
Future study will focus on validating the previous finding with the DBD-dependent 
and independent functions of Rev-erbα, studying the ligand regulation on those 
different mechanisms, and further establishing the link between circadian clock, 
nuclear receptors and liver metabolism by studying the mechanism of circadian 
misalignment induced hepatic steatosis.  
 
5.2a Overexpression of Rev-erbα and Its DNA Binding Domain In Vivo by 
AAV Vectors 
In Chapter 3, we reported that Rev-erbα could utilize two mechanisms to regulate 
its target gene expression. The DBD-dependent mechanism maintains the 
circadian expression of core clock genes, while the DBD-independent 
mechanism involves regulation of hepatic metabolism. It has been demonstrated 
that Rev-erbα regulation of clock genes mainly involves completion with RORs at 
its direct binding sites instead of recruitment of NCoR and HDAC3. Indeed, it has 
reported that Rev-erbα DBD alone is able to form homodimers and bind to the 
Rev-DR2 consensus site (Harding and Lazar, 1995). Because of this, we 
hypothesize that DNA binding domain alone could be sufficient to repress the 
clock genes transcription in vivo. To test this hypothesis, we have generated the 
AAV-vectors to over-express wild type Rev-erbα, Rev-DBD, Rev-DBD with 
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additional nuclear localization signal sequences, and Rev-erbα DBD-null mutant 
(Figure 5.1). We propose to over-express them in wild-type mouse liver, or in the 
liver of Rev-arbs deficient mice, and measure the circadian expression of Rev-
erbα target genes.  
 
Since the Bmal1 circadian expression were flattened by Rev-erbs deletion in 
mice liver, we expected the over-expression of wild-type Rev-erbα could help 
Bmal1 gene to regain circadian expression. In addition, because the repression 
of Bmal1 mainly involve DNA binding function of Rev-erbα, we hypothesized that 
the over-expression of Rev-erbα DNA binding domain could also bind to clock 
gene promoters and enhancers and rescue the Bmal1 circadian expression. The 
result will shed light on the possibility on regulate Rev-erbα DBD-depend target 
genes including clock genes, without disturbing the DBD-independent targets 
such as metabolic genes. 
 
5.2b Manipulating Cellular Heme Level by Alas1 Deletion in Mice 
In Chapter 3, we discussed that since Rev-erbα could regulate its target by two 
discrete mechanisms, the Rev-erbα ligands, such as its endogenous ligand 
Heme, which specifically affect Rev-erbα interaction with NCoR/HDAC3 without 
disrupting DNA-binding, could modulate liver metabolism with lesser effects on 
the integrity of the circadian clock. To test this hypothesis, we propose to reduce 
the cellular Heme level by deplete Alas1 proteins, which is the key enzyme in the 
 97 
Heme synthesis pathway, by generating the Alas1 floxed mutant mice using the 
CRISPR/Cas9 technology.  
 
We will inject AAV-TBG-Cre in the mice or cross these mice with various cre 
lines to induce Alas1 deletion in the major metabolic organs, such as liver and 
adipose tissues. We hypothesize that Heme level will be reduced in the mutant 
mice and play a role in regulating Rev-erbs trans-repression activity of the 
metabolic target genes, without affecting the integrity of the cellular clock circuit.  
 
5.2c Mechanisms of Circadian Misalignment Induced Hepatic Steatosis in 
Mice 
In human, the circadian misalignment has been associated with cardiovascular 
diseases and metabolic disorders (Morris et al., 2015; Morris et al., 2016). The 
mechanism of this still remains to be elucidated, but one possibility is that 
misalignment between the circadian clock gene expression and 
environmental/behavioral cycles leads to dysfunction of metabolic homeostasis. 
Since nuclear receptors Rev-erbs and RORs are of the most important clock 
factors that link to metabolism, we hypothesized that circadian misalignment 
might affect the liver metabolism through disruption of the normal functions of 
Rev-erbs and RORs.  
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To test this hypothesis, we first used a mice model to mimic the circadian 
misalignment. We put the mice on an ultradian 7-hour light: 7-hour dark schedule, 
which mimic the schedule of shift-working (Figure 5.2A). We found that the 
ultradian schedule resulted in increased body weight (Figure 5.2B) and 
accumulated hepatic triglycerides (Figure 5.2 C, D). For the next step, we 
propose to measure the food intake behavior of the ultradian mouse. We also 
plan to characterize the transcriptome profile of the mice on ultradian schedule 
throughout the 24-hour day, focusing on the expression of clock genes, as well 
as the metabolic genes targeted by Rev-erbs and RORs. We will compare the 
result of the food intake rhythm and clock gene expression rhythm to check if the 
misalignment exist between the two rhythms. In addition, we will also examine 
the Rev-erbs and RORs binding to their target genes, and test whether Rev-erbs 
and RORs circadian cistromes are also misaligned with the feeding behavior and 
thus contribute to the metabolic dysfunction. 
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Figure 5.1 Schematic of Rev-erbα Over-expression in mouse liver by AAV 
vectors. (A) Schematic of the over-expression vector for Rev-erbα, DBD domain, 
DBD domain with two NLS sequences, and the DBDm. Red color indicates the 
NLS signal. HF is short for HA-Flag tag protein. (B) Western blot for HA-tag in 
livers over-expressing the vectors. (C) Western blot for Rev-erbα using an 
antibody only detecting the C-terminal peptides.    
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Figure 5.2 Ultradian mice model results in hepatic steatosis. (A) Schedule 
and diet treatment in the ultradian mice model. (B) Body weight at the end of the 
study. (C) Hepatic Triglyercerides level at the end of the study. (D) Oil Red O 
staining of the circadian and the ultradian mice liver.   
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